syndrome	score	normalized_score
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0399225	100.0
BNAR SYNDROME	1.0	96.16101199849027
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0	96.16101199849027
PLACENTAL INSUFFICIENCY	0.25704225	24.717442886368936
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	24.040252999622567
TUBERCULOSIS	0.25	24.040252999622567
KAPOSI SARCOMA	0.25	24.040252999622567
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.14052279999999998	13.512814656861446
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.12736728	12.247766540295068
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.12174929999999999	11.70753589810779
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.119615734	11.50237003238222
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.11777766999999999	11.325619938024225
PANHYPOPITUITARISM	0.11777766999999999	11.325619938024225
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11672897999999998	11.224776846351528
PANHYPOPITUITARISM, X-LINKED	0.11111099999999999	10.684546204164251
PITUITARY DWARFISM IV	0.11111099999999999	10.684546204164251
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.109443602	10.524207525079992
MIRAGE SYNDROME; MIRAGE	0.108121354	10.397058819287015
TUBEROUS SCLEROSIS COMPLEX	0.10704225	10.293291086595396
NEUROLEPTIC MALIGNANT SYNDROME	0.1070381	10.292892018395602
DOORS SYNDROME	0.10173749400000001	9.783180381230332
PEROXISOME BIOGENESIS DISORDER 11B	0.100961538	9.708563667004032
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.1	9.616101199849027
AGEL AMYLOIDOSIS	0.1	9.616101199849027
IMMUNODEFICIENCY 15A; IMD15A	0.1	9.616101199849027
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.1	9.616101199849027
CRYPTOSPORIDIOSIS	0.1	9.616101199849027
CHOPS SYNDROME; CHOPS	0.09145465400000001	8.794372080611778
PMM2-CDG	0.09145465400000001	8.794372080611778
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.09145465400000001	8.794372080611778
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09145465400000001	8.794372080611778
MOHR-TRANEBJAERG SYNDROME	0.0909091	8.741911055871952
CLEFT VELUM	0.0909091	8.741911055871952
X-LINKED DYSTONIA-PARKINSONISM	0.0909091	8.741911055871952
RHEUMATOID ARTHRITIS	0.0901315	8.667136252941926
KABUKI SYNDROME 1	0.085317602	8.204226949604418
FONTAINE PROGEROID SYNDROME; FPS	0.08389807800000001	8.067724085208274
HOLOPROSENCEPHALY 7	0.08387885400000002	8.065875485913615
FRYNS MICROPHTHALMIA SYNDROME	0.08333330000000001	8.01341446117379
ZLOTOGORA-OGUR SYNDROME	0.08333330000000001	8.01341446117379
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.08333330000000001	8.01341446117379
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.08333330000000001	8.01341446117379
TELECANTHUS	0.08333330000000001	8.01341446117379
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.08333330000000001	8.01341446117379
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.08333330000000001	8.01341446117379
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.08333330000000001	8.01341446117379
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.08333330000000001	8.01341446117379
ANOPHTHALMIA PLUS SYNDROME	0.08333330000000001	8.01341446117379
SLC35A2-CDG	0.081768984	7.86298825152836
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.07547718	7.25796201159221
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.074639272	7.177387930350579
GAUCHER DISEASE, TYPE II	0.07367773400000001	7.084925463195575
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.07313218	7.03246443845575
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.07293569200000001	7.013569953530191
MARSHALL-SMITH SYNDROME; MRSHSS	0.072390138	6.961108928790366
OROFACIODIGITAL SYNDROME IX; OFD9	0.07197415400000001	6.921107486375187
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07197415400000001	6.921107486375187
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07142860000000001	6.868646461635362
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.07142860000000001	6.868646461635362
OCULOPHARYNGODISTAL MYOPATHY	0.07142860000000001	6.868646461635362
LAFORA DISEASE	0.07142860000000001	6.868646461635362
CUSHING SYNDROME	0.06851850000000001	6.588808300618557
ALSTROM SYNDROME; ALMS	0.063013214	6.059414427517434
HYDROXYKYNURENINURIA	0.060152854	5.784359315237433
COHEN SYNDROME	0.054457978	5.236734275871519
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.053972662	5.190065798172459
CLASSICAL EHLERS-DANLOS SYNDROME	0.05364146	5.158217078676536
TEMPLE SYNDROME	0.052883427999999996	5.085323954429296
NEONATAL LUPUS ERYTHEMATOSUS	0.05232474000000001	5.031599950957885
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0518518	4.9861215619433175
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0518518	4.9861215619433175
ACTH-INDEPENDENT CUSHING SYNDROME	0.0518518	4.9861215619433175
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0518518	4.9861215619433175
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.0518518	4.9861215619433175
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.051401634	4.942833143816006
SMITH-MAGENIS SYNDROME; SMS	0.051157021999999996	4.91931100634903
LICHTENSTEIN SYNDROME	0.050621160000000005	4.867781974137496
NEUROFIBROMATOSIS TYPE 1	0.050144970000000004	4.821991061833935
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.049096280000000006	4.721147970161238
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.048898018	4.702082895600393
CONGENITAL ANALBUMINEMIA	0.04832586	4.647063603297361
CORNELIA DE LANGE SYNDROME	0.04825079	4.639844796126634
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.047049730000000005	4.5243496510557275
CHARGE SYNDROME	0.046874453999999996	4.507494933516679
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.046840708	4.5042498840057785
WOODHOUSE-SAKATI SYNDROME	0.04617875	4.440595332825282
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	4.405405210484435
LYSINURIC PROTEIN INTOLERANCE	0.045675280000000006	4.392181148114403
ALSTRÖM SYNDROME	0.045332664	4.359234846827528
PSEUDOTRISOMY 13 SYNDROME	0.044439838	4.273379795128964
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	4.18091732797396
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	4.18091732797396
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	4.18091732797396
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	4.18091732797396
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	4.18091732797396
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	4.18091732797396
JUVENILE XANTHOGRANULOMA	0.043478300000000004	4.18091732797396
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	4.18091732797396
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	4.18091732797396
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	4.18091732797396
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	4.18091732797396
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	4.18091732797396
HYPOPLASMINOGENEMIA	0.043478300000000004	4.18091732797396
PGM3-CDG	0.0429385	4.129009613697174
NORRIE DISEASE	0.042280319999999996	4.065718358820008
SOTOS SYNDROME	0.04193746400000001	4.032748978890254
LARON SYNDROME	0.04185187	4.0245181732292545
MARFAN SYNDROME; MFS	0.04166663	4.006705307366655
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.04166663	4.006705307366655
MARFAN SYNDROME	0.04166663	4.006705307366655
GLYCOGEN STORAGE DISEASE VI	0.041626079999999996	4.002805978330115
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0399225	3.838988001509728
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0399225	3.838988001509728
HYPERLIPOPROTEINEMIA, TYPE I	0.0399225	3.838988001509728
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0399225	3.838988001509728
PSEUDOXANTHOMA ELASTICUM	0.038951280000000005	3.7455945034365543
GLYCOGEN STORAGE DISEASE IB	0.038768910000000004	3.7280576196783897
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03823796	3.6770009303577913
FETAL ALCOHOL SYNDROME	0.037888884	3.6434334289334056
LYSINURIC PROTEIN INTOLERANCE; LPI	0.037850318	3.6397248833446723
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.037828432	3.6376203034360732
DOWN SYNDROME	0.03776081	3.6311177034827113
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.03774511	3.6296079755943342
GALLOWAY-MOWAT SYNDROME	0.037520314	3.607991364741122
TRIMETHYLAMINURIA	0.03735636	3.5922253821799215
SMITH-MAGENIS SYNDROME	0.037116913999999994	3.569200012500931
22Q11.2 MICRODUPLICATION SYNDROME	0.036159204	3.477105649699857
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.036013254	3.4630709499986776
HELSMOORTEL-VAN DER AA SYNDROME	0.035806002	3.4431413879399666
PENTASOMY X	0.035783624	3.4409894968134647
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.035575334	3.4209601196242985
KEPPEN-LUBINSKY SYNDROME	0.0353611	3.400359161379814
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03520333	3.385187838516812
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0351852	3.38344443936928
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0351852	3.38344443936928
45,X/46,XY MIXED GONADAL DYSGENESIS	0.03512506	3.3776613161076905
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.034734934	3.3401464051407674
MAN1B1-CDG	0.034439634	3.3117500582976125
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.034421917999999996	3.310046469809048
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.034180578	3.286838971173333
NELSON SYNDROME	0.0333333	3.205363861249276
EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTINABNORMALITY	0.0333333	3.205363861249276
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.0333333	3.205363861249276
FAMILIAL CERVICAL ARTERY DISSECTION	0.0333333	3.205363861249276
STRIAE DISTENSAE, FAMILIAL	0.0333333	3.205363861249276
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0333333	3.205363861249276
LOEYS-DIETZ SYNDROME 3; LDS3	0.0333333	3.205363861249276
PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY	0.0333333	3.205363861249276
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.0333333	3.205363861249276
MAXILLONASAL DYSPLASIA	0.0333333	3.205363861249276
CHERUBISM	0.0333333	3.205363861249276
LOEYS-DIETZ SYNDROME	0.0333333	3.205363861249276
ACTH-DEPENDENT CUSHING SYNDROME	0.0333333	3.205363861249276
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0333333	3.205363861249276
ADRENOCORTICAL CARCINOMA	0.0333333	3.205363861249276
MYHRE SYNDROME	0.033308934	3.2030208020309203
DOUBLE OUTLET RIGHT VENTRICLE	0.0330782	3.180833187088461
19P13.12 MICRODELETION SYNDROME	0.032990764	3.1724252528433605
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0327957	3.153667701198887
RELAPSING FEVER	0.0327957	3.153667701198887
NAVAJO NEUROHEPATOPATHY	0.032622472	3.1370099214124125
COFS SYNDROME	0.03261998	3.136770288170512
SCHWARTZ-JAMPEL SYNDROME	0.03261998	3.136770288170512
CONGENITAL ENTEROVIRUS INFECTION	0.03221292	3.097626986626407
9Q33.3Q34.11 MICRODELETION SYNDROME	0.03218467	3.0949104380374495
ACRODYSOSTOSIS	0.03214283	3.0908870612954322
GRISCELLI SYNDROME TYPE 2	0.032102240000000004	3.0869838858184147
TURNPENNY-FRY SYNDROME; TPFS	0.031826174	3.0604370998800388
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.03162605	3.0411929735148533
GLYCOGEN STORAGE DISEASE IA	0.03162605	3.0411929735148533
TRICHOHEPATOENTERIC SYNDROME 1	0.031115379999999998	2.9920864295175837
PROPIONIC ACIDEMIA	0.030820534	2.963733739773877
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.03065812	2.9481158451711544
INSULIN-RESISTANCE SYNDROME TYPE B	0.030555600000000002	2.9382574182210695
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030373338	2.9207309198522
SYSTEMIC MASTOCYTOSIS	0.030275079999999996	2.9112823311352525
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.030275079999999996	2.9112823311352525
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.030225514000000002	2.9065160144145357
PRIMROSE SYNDROME; PRIMS	0.030093718	2.893842377677182
ISOLATED CEREBELLAR AGENESIS	0.03004853	2.889497053866995
NEUROFERRITINOPATHY	0.03004853	2.889497053866995
GRAFT VERSUS HOST DISEASE	0.0300179	2.886551642069481
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	2.8807294774370202
MOSAIC MONOSOMY X	0.02992247	2.8773749966944653
TURNER SYNDROME	0.02992247	2.8773749966944653
MONOSOMY X	0.02992247	2.8773749966944653
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.02992247	2.8773749966944653
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.02992247	2.8773749966944653
FABRY DISEASE	0.02992247	2.8773749966944653
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029825942	2.868092766528275
7Q11.23 MICRODUPLICATION SYNDROME	0.029815498000000003	2.867088460918963
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.029709424	2.856888277732235
ECHO VIRUS 11 SENSITIVITY	0.0294118	2.8282684526971957
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	2.8282684526971957
AMYLOIDOSIS	0.0294118	2.8282684526971957
MONOMELIC AMYOTROPHY	0.0294118	2.8282684526971957
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	2.8282684526971957
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	2.8282684526971957
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	2.8282684526971957
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	2.8282684526971957
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	2.8282684526971957
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	2.8282684526971957
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	2.8282684526971957
MYASTHENIA GRAVIS; MG	0.0294118	2.8282684526971957
MYELOPEROXIDASE DEFICIENCY	0.0294118	2.8282684526971957
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	2.8282684526971957
IMMUNE SUPPRESSION	0.0294118	2.8282684526971957
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	2.8282684526971957
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	2.8282684526971957
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	2.8282684526971957
RAGWEED SENSITIVITY	0.0294118	2.8282684526971957
SHORT SYNDROME	0.0294118	2.8282684526971957
FOLATE MALABSORPTION, HEREDITARY	0.029365232	2.8237904266904503
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.029302154	2.8177247823756097
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.02921311	2.809162221223216
22Q11.2 DELETION SYNDROME	0.029159163999999994	2.8039747192699447
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.0291568	2.803747394637581
CONGENITAL DISORDER OF GLYCOSYLATION	0.029116954	2.7999157629534888
ALG1-CDG	0.029116954	2.7999157629534888
TETRASOMY X	0.029116954	2.7999157629534888
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029116954	2.7999157629534888
CAMURATI-ENGELMANN DISEASE	0.02908553	2.796893999312448
FAMILIAL DYSAUTONOMIA	0.028949509999999998	2.7838141784604136
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.02887378	2.7765319050217685
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0285715	2.7474643543148645
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	2.7474547382136647
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	2.7474547382136647
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	2.7474547382136647
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	2.7474547382136647
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	2.7474547382136647
ALPHA-THALASSEMIA	0.0285714	2.7474547382136647
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	2.7474547382136647
COG7-CDG	0.0285714	2.7474547382136647
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	2.7474547382136647
ALG12-CDG	0.0285714	2.7474547382136647
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	2.7474547382136647
CONGENITAL LOBAR EMPHYSEMA	0.0285714	2.7474547382136647
DISTAL MONOSOMY 7Q36	0.0285714	2.7474547382136647
C SYNDROME	0.0285714	2.7474547382136647
CHEILITIS GLANDULARIS	0.0285714	2.7474547382136647
TIMOTHY SYNDROME; TS	0.028056222000000002	2.6979147003743065
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02798801	2.6913553654238656
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.027973400000000002	2.6899504530385676
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.027645602000000002	2.658429065627487
BRONCHIAL NEUROENDOCRINE TUMOR	0.02749728	2.644166272005846
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.02749728	2.644166272005846
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.027450564	2.639674014169325
OCULOCEREBRORENAL SYNDROME OF LOWE	0.02738195	2.6330760224920606
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.027232040000000002	2.6186605251833672
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.027134844	2.6093140594611617
WOLFRAM-LIKE SYNDROME	0.026932570000000003	2.589863186920179
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.02685183	2.5820991468114207
16P12.1P12.3 TRIPLICATION SYNDROME	0.026767299999999997	2.5739706564671883
BRAIN-LUNG-THYROID SYNDROME	0.026534853999999997	2.551618413872187
CHROMOSOME 9P DELETION SYNDROME	0.026392802000000003	2.5379585497957784
CORNELIA DE LANGE SYNDROME 1	0.02623226	2.522520668607516
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.026058694	2.505830386398986
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.026031598	2.503224807617875
CYSTIC FIBROSIS	0.0259893	2.499157389132363
HALLERMANN-STREIFF SYNDROME; HSS	0.02598926	2.499153542691883
MICROFORM HOLOPROSENCEPHALY	0.02592614	2.493083859614538
PYRUVATE DEHYDROGENASE DEFICIENCY	0.025870734	2.48775596258375
PRADER-WILLI SYNDROME; PWS	0.025854312	2.486176806444711
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.0257937	2.4803482951854585
PRIMARY CILIARY DYSKINESIA	0.0257937	2.4803482951854585
CASPASE 8 DEFICIENCY	0.0257937	2.4803482951854585
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.0257937	2.4803482951854585
ROIFMAN SYNDROME; RFMN	0.025698532	2.4711968439955863
KIKUCHI-FUJIMOTO DISEASE	0.02551314	2.453369361659162
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.02532518	2.4352949378439255
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.02528253	2.43119367068219
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.025268354	2.4298304921760994
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.025205194	2.423756962658275
SHORT STATURE DUE TO PRIMARY ACID-LABILE SUBUNIT DEFICIENCY	0.02518517	2.421831434554017
ADAMS-OLIVER SYNDROME	0.025070059999999998	2.410762340462871
GAUCHER DISEASE TYPE 1	0.02503695	2.4075784493556007
LOWE OCULOCEREBRORENAL SYNDROME	0.02500003	2.404028184792616
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.02495938	2.400119239654878
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.02495938	2.400119239654878
TRISOMY 18-LIKE SYNDROME	0.024885710000000002	2.393035057900949
MECKEL SYNDROME, TYPE 10; MKS10	0.024885710000000002	2.393035057900949
GRISCELLI SYNDROME TYPE 1	0.024762892	2.3812247547293186
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.02472531	2.377610831576391
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.024682034	2.3734493676211446
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.024577408000000002	2.363388425579791
AICARDI-GOUTIERES SYNDROME 7	0.024487272	2.354720856602295
MICROTRIPLICATION 11Q24.1	0.024217338	2.328763729989494
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.024206164000000002	2.3276892268414233
DYSBETALIPOPROTEINEMIA	0.023988259999999997	2.306735357682904
SARCOIDOSIS	0.023988259999999997	2.306735357682904
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.023944694	2.3025460070341777
KASABACH-MERRITT SYNDROME	0.02380956	2.2895513848387736
ACUTE PROMYELOCYTIC LEUKEMIA	0.02380956	2.2895513848387736
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.023801354	2.288762287574314
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.023622368	2.2715508126807524
48,XXYY SYNDROME	0.023541184	2.2637440770826673
CHROMOSOME 18Q DELETION SYNDROME	0.023504637999999998	2.26022977673817
MELAS	0.023375479999999997	2.247809812750469
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.02333337	2.2437604725352127
GABRIELE-DE VRIES SYNDROME	0.023298529999999998	2.240410222877185
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.0232558	2.23630126283449
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0232558	2.23630126283449
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.0232558	2.23630126283449
ACUTE INTERMITTENT PORPHYRIA	0.0232558	2.23630126283449
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0232558	2.23630126283449
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0232558	2.23630126283449
AROMATASE DEFICIENCY	0.0232558	2.23630126283449
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0232558	2.23630126283449
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0232558	2.23630126283449
FAMILIAL MULTIPLE LIPOMATOSIS	0.0232558	2.23630126283449
WOODHOUSE-SAKATI SYNDROME	0.0232558	2.23630126283449
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0232558	2.23630126283449
PRIMARY LIPODYSTROPHY	0.0232558	2.23630126283449
WITTEVEEN-KOLK SYNDROME	0.023236222	2.2344186225415834
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.023112734	2.2225438914919136
TEMPLE SYNDROME	0.023090239999999998	2.2203808456880196
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.023088654	2.2202283343229903
48,XXXY SYNDROME	0.023064033999999997	2.2178608502075874
49,XXXXY SYNDROME	0.023064033999999997	2.2178608502075874
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02298018	2.209797364707466
FELTY SYNDROME	0.02293094	2.2050623964766607
CHARGE SYNDROME	0.022922949999999997	2.204294069990792
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.022783692	2.190902879781907
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.022783692	2.190902879781907
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.022783692	2.190902879781907
JOUBERT SYNDROME 30; JBTS30	0.022783692	2.190902879781907
16P13.2 MICRODELETION SYNDROME	0.022733193999999998	2.186046940998007
CRYPTOCOCCOSIS	0.02266083	2.179088345525748
PRADER-WILLI SYNDROME (TYPE 1)	0.02256708	2.1700732506508897
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.02256708	2.1700732506508897
PRADER-WILLI SYNDROME (TYPE 2)	0.02256708	2.1700732506508897
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.02254306	2.167763463142686
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.022438242	2.1576840581870282
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.022428232	2.1567214864569233
CRANIOECTODERMAL DYSPLASIA 4	0.02241783	2.1557212196101148
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.02241783	2.1557212196101148
SUSAC SYNDROME	0.022238138	2.1384418550420823
ADNP SYNDROME	0.02208993	2.1241900237758102
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.021825512	2.098763321305193
PEHO SYNDROME	0.021822154	2.0984404126269025
CEDNIK SYNDROME	0.021822154	2.0984404126269025
WYBURN-MASON SYNDROME	0.021822154	2.0984404126269025
JOUBERT SYNDROME 23; JBTS23	0.021822154	2.0984404126269025
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.021822154	2.0984404126269025
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	2.0984404126269025
OROFACIODIGITAL SYNDROME TYPE 4	0.021822154	2.0984404126269025
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.021822154	2.0984404126269025
DYSTONIA 28, CHILDHOOD-ONSET	0.021822154	2.0984404126269025
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.021822154	2.0984404126269025
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.021718558000000002	2.088478516427907
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.021672304	2.0840306849789285
STÜVE-WIEDEMANN SYNDROME	0.021571359999999998	2.074323807783753
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.021466694	2.064259019301919
SPINOCEREBELLAR ATAXIA 12	0.0212766	2.045979387887078
3MC SYNDROME 1	0.0212766	2.045979387887078
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	2.045979387887078
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	2.045979387887078
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	2.045979387887078
X-LINKED RETINOSCHISIS	0.0212766	2.045979387887078
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0212766	2.045979387887078
HUNTINGTON DISEASE; HD	0.0212766	2.045979387887078
RAVINE SYNDROME	0.0212766	2.045979387887078
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	2.045979387887078
JUVENILE MYOCLONIC EPILEPSY	0.0212766	2.045979387887078
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	2.045979387887078
PRIMARY BASILAR INVAGINATION	0.0212766	2.045979387887078
KURU, SUSCEPTIBILITY TO	0.0212766	2.045979387887078
JUVENILE ABSENCE EPILEPSY	0.0212766	2.045979387887078
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0212766	2.045979387887078
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.0212766	2.045979387887078
X-LINKED AGAMMAGLOBULINEMIA	0.02122736	2.0412444196562722
WHIM SYNDROME	0.02122736	2.0412444196562722
OMENN SYNDROME	0.02121046	2.0396192985534976
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.021139118	2.0327589796355015
BETA-THALASSEMIA MAJOR	0.02113109	2.0319869990311776
PIERPONT SYNDROME	0.021066184	2.0257455723864037
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.021066184	2.0257455723864037
CHROMOSOME 2Q37 DELETION SYNDROME	0.021066184	2.0257455723864037
SLC35A1-CDG	0.02103176	2.0224353257093677
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.02103176	2.0224353257093677
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.02103176	2.0224353257093677
RAMOS-ARROYO SYNDROME	0.02099778	2.0191677745216587
LEUKOCYTE ADHESION DEFICIENCY	0.020931150000000003	2.0127605662922
1P36 DELETION SYNDROME	0.020825793999999998	2.0026294267120863
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02081283	2.001382795352538
OCULO-PALATO-CEREBRAL SYNDROME	0.020783683999999997	1.99858008649683
IMMUNODEFICIENCY 23; IMD23	0.020554752	1.9765657536979917
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.02052063	1.9732845476465792
XYLT1-CDG	0.02022208	1.94457567751443
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.020081902000000002	1.931096019174506
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020025592000000002	1.9256811925888708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.019988878	1.9221507371943582
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.019877372	1.9114282073904545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.019877372	1.9114282073904545
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.019877372	1.9114282073904545
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.019877372	1.9114282073904545
BECKWITH-WIEDEMANN SYNDROME	0.0197735	1.901439770752147
DUPLICATION/INVERSION 15Q11	0.019577708	1.882612213890939
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.019517184	1.8767921648007422
KLEEFSTRA SYNDROME	0.019511728000000002	1.8762675103192787
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.01950688	1.8758013217331098
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.01950688	1.8758013217331098
MENTAL RETARDATION, X-LINKED 12; MRX12	0.019480038	1.8732201678490465
COFFIN-SIRIS SYNDROME 1; CSS1	0.019242054	1.8503353855695976
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.019161763999999998	1.8426146179162388
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.019161763999999998	1.8426146179162388
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.019094618	1.836157790604588
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.019066752	1.8334781678442384
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.019064054	1.8332187254338665
XQ27.3Q28 DUPLICATION SYNDROME	0.019064054	1.8332187254338665
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.019064054	1.8332187254338665
WILSON-TURNER SYNDROME	0.019064054	1.8332187254338665
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.019064054	1.8332187254338665
BARATELA-SCOTT SYNDROME	0.019064054	1.8332187254338665
CARTILAGE-HAIR HYPOPLASIA; CHH	0.01904762	1.8316384153626832
CRI-DU-CHAT SYNDROME	0.01902734	1.829688270039354
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01894498	1.821768449091158
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.018915834	1.8189657402354502
GRISCELLI SYNDROME	0.018915834	1.8189657402354502
CITRULLINEMIA TYPE II	0.018915834	1.8189657402354502
MEHMO SYNDROME; MEHMO	0.018812062	1.8089869196983428
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.018794118	1.8072614064990415
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.018651760000000003	1.7935721171529613
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.0185185	1.7807577006940418
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.0185185	1.7807577006940418
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0185185	1.7807577006940418
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0185185	1.7807577006940418
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0185185	1.7807577006940418
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0185185	1.7807577006940418
XP22.13P22.2 DUPLICATION SYNDROME	0.0185185	1.7807577006940418
CUSHING DISEASE	0.0185185	1.7807577006940418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.0185185	1.7807577006940418
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.0185185	1.7807577006940418
MEGALENCEPHALY	0.0185185	1.7807577006940418
17Q24.2 MICRODELETION SYNDROME	0.0185185	1.7807577006940418
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0185185	1.7807577006940418
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0185185	1.7807577006940418
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0185185	1.7807577006940418
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.0185185	1.7807577006940418
MONOSOMY 18P	0.018506894	1.7796416559887875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.018456292000000003	1.7747757164596403
COFFIN-SIRIS SYNDROME 6; CSS6	0.018456292000000003	1.7747757164596403
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.018456292000000003	1.7747757164596403
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.018456292000000003	1.7747757164596403
ADAMS-OLIVER SYNDROME 2; AOS2	0.018456292000000003	1.7747757164596403
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018456292000000003	1.7747757164596403
COHEN SYNDROME	0.018403664	1.7697149547201834
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.018378133999999997	1.7672599640838615
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.018378133999999997	1.7672599640838615
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.018378133999999997	1.7672599640838615
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.01837028	1.7665047154956255
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.01837028	1.7665047154956255
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01837028	1.7665047154956255
LYSOSOMAL ACID LIPASE DEFICIENCY	0.01837028	1.7665047154956255
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.01837028	1.7665047154956255
GLYCOGEN STORAGE DISEASE IXA	0.01837028	1.7665047154956255
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.01837028	1.7665047154956255
IMMUNODEFICIENCY 47	0.01837028	1.7665047154956255
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.01837028	1.7665047154956255
DENGUE FEVER	0.01837028	1.7665047154956255
CHOLESTERYL ESTER STORAGE DISEASE	0.01837028	1.7665047154956255
MIXED CONNECTIVE TISSUE DISEASE	0.01837028	1.7665047154956255
BABESIOSIS	0.01837028	1.7665047154956255
LEISHMANIASIS	0.01837028	1.7665047154956255
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.018226104	1.7526406054297314
POTOCKI-LUPSKI SYNDROME	0.018215902	1.7516595707853226
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.018173792	1.7476102305700667
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01813308	1.7436953234495838
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.018068334	1.7374692825667295
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.017910738000000002	1.7223146917198155
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.017910738000000002	1.7223146917198155
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.017832579999999997	1.7147989393440373
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.017832579999999997	1.7147989393440373
PLAGUE	0.017832579999999997	1.7147989393440373
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.017832579999999997	1.7147989393440373
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.017832579999999997	1.7147989393440373
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.017832579999999997	1.7147989393440373
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.017628238	1.695149205830242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.017494754	1.6823132493046358
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.017494754	1.6823132493046358
ZECHI-CEIDE SYNDROME	0.017494754	1.6823132493046358
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.017494754	1.6823132493046358
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.017494754	1.6823132493046358
COMMON VARIABLE IMMUNODEFICIENCY	0.01746033	1.6790030026275997
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01734971	1.6683656714803268
PRADER-WILLI SYNDROME	0.01734971	1.6683656714803268
FUNCTIONING GONADOTROPIC ADENOMA	0.01730497	1.6640634278035142
OLIVER-MCFARLANE SYNDROME	0.01730497	1.6640634278035142
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.01730497	1.6640634278035142
ANE SYNDROME	0.01730497	1.6640634278035142
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.01730497	1.6640634278035142
POST-TRAUMATIC PITUITARY DEFICIENCY	0.01730497	1.6640634278035142
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.01730497	1.6640634278035142
MEIER-GORLIN SYNDROME 6; MGORS6	0.01730497	1.6640634278035142
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.017295172	1.663121242207953
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.65795047227077
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.65795047227077
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.65795047227077
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.65795047227077
MOTION SICKNESS	0.0172414	1.65795047227077
TRANSSEXUALITY	0.0172414	1.65795047227077
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.65795047227077
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.65795047227077
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.65795047227077
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.65795047227077
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.65795047227077
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.65795047227077
MOSAIC TRISOMY 15	0.0172414	1.65795047227077
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.65795047227077
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.65795047227077
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.65795047227077
ERYTHERMALGIA, PRIMARY	0.0172414	1.65795047227077
PALMOMENTAL REFLEX	0.0172414	1.65795047227077
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.65795047227077
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.65795047227077
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.65795047227077
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.65795047227077
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.65795047227077
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.65795047227077
THUMBS, CONGENITAL CLASPED	0.0172414	1.65795047227077
CARDIAC ARRHYTHMIA	0.0172414	1.65795047227077
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.65795047227077
CERVICAL RIB	0.0172414	1.65795047227077
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.65795047227077
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.65795047227077
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.65795047227077
ALCOHOL DEPENDENCE	0.0172414	1.65795047227077
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.65795047227077
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.65795047227077
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.65795047227077
269800 SENILE PLAQUE FORMATION	0.0172414	1.65795047227077
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.65795047227077
DIASTEMATOMYELIA	0.0172414	1.65795047227077
MYOPATHY, CONGENITAL	0.0172414	1.65795047227077
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.65795047227077
JUMPING FRENCHMAN OF MAINE	0.0172414	1.65795047227077
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.65795047227077
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.65795047227077
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.65795047227077
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.65795047227077
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.65795047227077
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.65795047227077
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.65795047227077
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.65795047227077
SICKLE CELL ANEMIA	0.0172414	1.65795047227077
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.017217818	1.6556828032858215
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.017212254	1.655147763415062
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.017212254	1.655147763415062
COG4-CDG	0.017212254	1.655147763415062
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.017212254	1.655147763415062
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.017212254	1.655147763415062
FANCONI ANEMIA	0.017212254	1.655147763415062
DIAMOND-BLACKFAN ANEMIA 5	0.017212254	1.655147763415062
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.017212254	1.655147763415062
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.017212254	1.655147763415062
LYSOSOMAL ACID LIPASE DEFICIENCY	0.017212254	1.655147763415062
PELIZAEUS-MERZBACHER DISEASE	0.017175290000000003	1.65159326776755
RAYNAUD-CLAES SYNDROME; MRXSRC	0.016990432	1.633817135411533
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0169492	1.6298522245648113
ZECHI-CEIDE SYNDROME	0.0169492	1.6298522245648113
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0169492	1.6298522245648113
MONOSOMY 22	0.0169492	1.6298522245648113
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0169492	1.6298522245648113
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.0169492	1.6298522245648113
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0169492	1.6298522245648113
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0169492	1.6298522245648113
FETAL AKINESIA SYNDROME, X-LINKED	0.0169492	1.6298522245648113
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0169492	1.6298522245648113
OMODYSPLASIA 1; OMOD1	0.0169492	1.6298522245648113
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0169492	1.6298522245648113
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0169492	1.6298522245648113
FRYNS SYNDROME; FRNS	0.0169492	1.6298522245648113
FEINGOLD SYNDROME 1; FGLDS1	0.0169492	1.6298522245648113
20P13 MICRODELETION SYNDROME	0.0169492	1.6298522245648113
RAPADILINO SYNDROME	0.0169492	1.6298522245648113
PFEIFFER-PALM-TELLER SYNDROME	0.0169492	1.6298522245648113
JUBERG-MARSIDI SYNDROME	0.0169492	1.6298522245648113
VELOCARDIOFACIAL SYNDROME	0.0169492	1.6298522245648113
PHELAN-MCDERMID SYNDROME	0.016882672	1.6234548247585758
SRD5A3-CDG	0.016801833999999998	1.6156813608706415
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.016801833999999998	1.6156813608706415
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.016801833999999998	1.6156813608706415
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.016749618	1.6106602174681284
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01670844	1.606700499316055
HYDROXYKYNURENINURIA	0.016674553999999998	1.6034419872634738
DISTAL MYOPATHY, TATEYAMA TYPE	0.0166667	1.6026867386752377
EBOLA HEMORRHAGIC FEVER	0.0166667	1.6026867386752377
RETICULAR DYSGENESIS	0.0166667	1.6026867386752377
CEREBROTENDINOUS XANTHOMATOSIS	0.0166667	1.6026867386752377
HERMANSKY-PUDLAK SYNDROME 9	0.0166667	1.6026867386752377
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0166667	1.6026867386752377
ACUTE ERYTHROID LEUKEMIA	0.0166667	1.6026867386752377
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0166667	1.6026867386752377
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0166667	1.6026867386752377
SITOSTEROLEMIA	0.0166667	1.6026867386752377
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.0166667	1.6026867386752377
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.0166667	1.6026867386752377
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0166667	1.6026867386752377
ALPORT SYNDROME	0.0166667	1.6026867386752377
XANTHOMATOSIS, SUSCEPTIBILITY TO	0.0166667	1.6026867386752377
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0166667	1.6026867386752377
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.0166667	1.6026867386752377
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.0166667	1.6026867386752377
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0166667	1.6026867386752377
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0166667	1.6026867386752377
MYELOLYMPHATIC INSUFFICIENCY	0.0166667	1.6026867386752377
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0166667	1.6026867386752377
MARBURG HEMORRHAGIC FEVER	0.0166667	1.6026867386752377
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0166667	1.6026867386752377
VIRAL HEMORRHAGIC FEVER	0.0166667	1.6026867386752377
ALAGILLE SYNDROME 1; ALGS1	0.0166667	1.6026867386752377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.0166667	1.6026867386752377
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0166667	1.6026867386752377
LASSA FEVER	0.0166667	1.6026867386752377
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0166667	1.6026867386752377
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.0166667	1.6026867386752377
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.0166667	1.6026867386752377
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0166667	1.6026867386752377
MANDIBULOACRAL DYSPLASIA	0.0166667	1.6026867386752377
HYPERCHOLESTEROLEMIA, FAMILIAL	0.0166667	1.6026867386752377
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	0.0166667	1.6026867386752377
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0166667	1.6026867386752377
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0166667	1.6026867386752377
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0166667	1.6026867386752377
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.016551832000000002	1.5916409155489954
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.016551832000000002	1.5916409155489954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.016551832000000002	1.5916409155489954
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.016518058	1.588393173529758
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.016407148	1.5777279556890056
POTOCKI-SHAFFER SYNDROME	0.016401634000000002	1.5771977238688462
KNIEST-LIKE DYSPLASIA, LETHAL	0.01633987	1.571258435123771
RESTRICTIVE DERMOPATHY, LETHAL	0.01633987	1.571258435123771
15Q26 OVERGROWTH SYNDROME	0.01626984	1.564524279453517
HYPOTONIA-CYSTINURIA SYNDROME	0.016193972	1.5572287357952155
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.016155012	1.5534823027677542
BUTYRYLCHOLINESTERASE	0.016128999999999998	1.5509809625236493
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.016128999999999998	1.5509809625236493
PARAGANGLIOMAS 1	0.016128999999999998	1.5509809625236493
MERCURY POISONING	0.016128999999999998	1.5509809625236493
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.016128999999999998	1.5509809625236493
DYSTROPHIA MYOTONICA 2	0.016128999999999998	1.5509809625236493
PORPHYRIA VARIEGATA	0.016128999999999998	1.5509809625236493
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.016128999999999998	1.5509809625236493
PARAGANGLIOMAS 4	0.016128999999999998	1.5509809625236493
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.016128999999999998	1.5509809625236493
CONGENITAL FIBRINOGEN DEFICIENCY	0.016128999999999998	1.5509809625236493
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.016128999999999998	1.5509809625236493
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.016128999999999998	1.5509809625236493
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.016128999999999998	1.5509809625236493
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.016128999999999998	1.5509809625236493
PARAGANGLIOMAS 3	0.016128999999999998	1.5509809625236493
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.016128999999999998	1.5509809625236493
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.016128999999999998	1.5509809625236493
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.016128999999999998	1.5509809625236493
TETANUS	0.016128999999999998	1.5509809625236493
STIFF-PERSON SYNDROME; SPS	0.016128999999999998	1.5509809625236493
PAROXYSMAL EXTREME PAIN DISORDER	0.016128999999999998	1.5509809625236493
LONG QT SYNDROME 13; LQT13	0.016128999999999998	1.5509809625236493
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.016128999999999998	1.5509809625236493
CARNEY TRIAD	0.016128999999999998	1.5509809625236493
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	0.016128999999999998	1.5509809625236493
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.016128999999999998	1.5509809625236493
PHEOCHROMOCYTOMA	0.016128999999999998	1.5509809625236493
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.016128999999999998	1.5509809625236493
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.016128999999999998	1.5509809625236493
HEREDITARY COPROPORPHYRIA	0.016128999999999998	1.5509809625236493
ACQUIRED METHEMOGLOBINEMIA	0.016128999999999998	1.5509809625236493
POTASSIUM-AGGRAVATED MYOTONIA	0.01595338	1.5340931655964747
AORTIC ARCH DEFECTS	0.01595338	1.5340931655964747
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.01578808	1.518197750313124
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.01578808	1.518197750313124
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.01578808	1.518197750313124
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.01578808	1.518197750313124
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.01578808	1.518197750313124
RITSCHER-SCHINZEL SYNDROME 1	0.015716822	1.5113455089201355
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.015609458	1.5010212780279297
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.01559248	1.4993886563662195
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01559248	1.4993886563662195
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.01559248	1.4993886563662195
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.01559248	1.4993886563662195
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.01559248	1.4993886563662195
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.01559248	1.4993886563662195
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.01559248	1.4993886563662195
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.015591592	1.4993032653875649
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.015591592	1.4993032653875649
1P21.3 MICRODELETION SYNDROME	0.015590294000000001	1.4991784483939907
DIAMOND-BLACKFAN ANEMIA 1	0.01554622	1.4949402479511693
DEAFNESS-HYPOGONADISM SYNDROME	0.0154386	1.4845913998398919
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.0154386	1.4845913998398919
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.015425957999999998	1.4833757323262067
RIGID SPINE SYNDROME	0.015395992	1.48049417144066
MENTAL RETARDATION, X-LINKED 21	0.01537558	1.4785313328637468
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.015361362	1.4771641155951525
XQ28 (MECP2) DUPLICATION	0.015207814	1.4623987845248083
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.015171268	1.4588844841803112
SILVER-RUSSELL SYNDROME	0.01511477	1.4534515793244207
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.015070030000000002	1.4491493356476084
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.015070030000000002	1.4491493356476084
ROIFMAN SYNDROME	0.015046038	1.4468422406477404
AICARDI SYNDROME; AIC	0.015046038	1.4468422406477404
EHLERS-DANLOS SYNDROME, TYPE VI	0.015046038	1.4468422406477404
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.014876974000000001	1.4305848753152277
TENORIO SYNDROME; TNORS	0.014850438	1.4280331467008358
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.014850438	1.4280331467008358
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.014850438	1.4280331467008358
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.014670457999999999	1.4107260877613472
RIDDLE SYNDROME	0.014630054	1.4068407982325604
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.014630054	1.4068407982325604
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.014630054	1.4068407982325604
LIGNEOUS CONJUNCTIVITIS	0.014630054	1.4068407982325604
MONOSOMY 18Q	0.014496864	1.3940331130444814
WOLCOTT-RALLISON SYNDROME	0.014464419999999999	1.3909132651712024
ROIFMAN-CHITAYAT SYNDROME	0.014434454000000001	1.3880317042856558
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.014434454000000001	1.3880317042856558
METHYLMALONIC ACIDURIA, CBLB TYPE	0.014402112	1.3849216648356006
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014402112	1.3849216648356006
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.01438991	1.383748308167195
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.014267931999999999	1.3720187802456432
17Q21.31 MICRODUPLICATION SYNDROME	0.014254474	1.3707246453461674
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.014173058	1.3628956003932986
ZELLWEGER SYNDROME	0.014155520000000001	1.361209128564869
MEIER-GORLIN SYNDROME 3; MGORS3	0.0140845	1.354379773492736
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	1.354379773492736
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0140845	1.354379773492736
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0140845	1.354379773492736
PULMONARY BLASTOMA	0.0140845	1.354379773492736
MASP2 DEFICIENCY	0.0140845	1.354379773492736
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0140845	1.354379773492736
CILIARY DYSKINESIA, PRIMARY, 33	0.0140845	1.354379773492736
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0140845	1.354379773492736
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0140845	1.354379773492736
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0140845	1.354379773492736
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0140845	1.354379773492736
CADASIL	0.0140845	1.354379773492736
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0140845	1.354379773492736
NIJMEGEN BREAKAGE SYNDROME	0.0140845	1.354379773492736
TRACHEOPATHIA OSTEOPLASTICA	0.0140845	1.354379773492736
SCHINZEL-GIEDION SYNDROME	0.0140845	1.354379773492736
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0140845	1.354379773492736
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0140845	1.354379773492736
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140845	1.354379773492736
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.0140845	1.354379773492736
NIJMEGEN BREAKAGE SYNDROME	0.0140845	1.354379773492736
ROWLEY-ROSENBERG SYNDROME	0.0140845	1.354379773492736
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0140845	1.354379773492736
KOOLEN-DE VRIES SYNDROME; KDVS	0.013889002000000001	1.3355804879690554
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.013889002000000001	1.3355804879690554
HENNEKAM-BEEMER SYNDROME	0.013888900000000001	1.3355706795458315
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.013888900000000001	1.3355706795458315
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.013888900000000001	1.3355706795458315
IMMUNODEFICIENCY 13; IMD13	0.013888900000000001	1.3355706795458315
215030 CHOLESTEROL PNEUMONIA	0.013888900000000001	1.3355706795458315
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.013888900000000001	1.3355706795458315
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.013888900000000001	1.3355706795458315
IMMUNODEFICIENCY 32B; IMD32B	0.013888900000000001	1.3355706795458315
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.013888900000000001	1.3355706795458315
MICROSPORIDIOSIS	0.013888900000000001	1.3355706795458315
NOCARDIOSIS	0.013888900000000001	1.3355706795458315
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.013888900000000001	1.3355706795458315
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.013888900000000001	1.3355706795458315
MELIOIDOSIS	0.013888900000000001	1.3355706795458315
ISOLATED AGAMMAGLOBULINEMIA	0.013888900000000001	1.3355706795458315
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.013888900000000001	1.3355706795458315
MOUNIER-KÜHN SYNDROME	0.013888900000000001	1.3355706795458315
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.013888900000000001	1.3355706795458315
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013888900000000001	1.3355706795458315
MUSCULAR HYPERTONIA, LETHAL	0.013888900000000001	1.3355706795458315
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.013888900000000001	1.3355706795458315
WHITE-SUTTON SYNDROME; WHSUS	0.013850452000000001	1.3318734809565136
TRANSALDOLASE DEFICIENCY	0.013608379999999998	1.3085955924600148
MUCOPOLYSACCHARIDOSIS, TYPE II	0.013608379999999998	1.3085955924600148
MASTOCYTOSIS	0.013608379999999998	1.3085955924600148
CUTANEOUS MASTOCYTOSIS	0.013608379999999998	1.3085955924600148
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.013608379999999998	1.3085955924600148
PROPIONIC ACIDEMIA	0.013440574	1.2924591976805964
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.013413478000000001	1.2898536188994854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.013411891999999998	1.2897011075344553
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.013411891999999998	1.2897011075344553
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.013411852	1.2896972610939756
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.013411852	1.2896972610939756
ASPARTYLGLUCOSAMINURIA; AGU	0.013379408	1.2865774132206969
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.013343448	1.2831194632292309
NOONAN SYNDROME 7; NS7	0.013343448	1.2831194632292309
AL KAISSI SYNDROME; ALKAS	0.013015032000000001	1.2515386483127349
DESANTO-SHINAWI SYNDROME	0.013015032000000001	1.2515386483127349
JACOBSEN SYNDROME	0.012997494000000002	1.2498521764843054
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012997494000000002	1.2498521764843054
CARDIOFACIOCUTANEOUS SYNDROME	0.012997494000000002	1.2498521764843054
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.012877232	1.238287660859343
PITUITARY STALK INTERRUPTION SYNDROME	0.012830204000000001	1.233765400787078
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.012830204000000001	1.233765400787078
2Q33.1 DELETION SYNDROME	0.01282051	1.2328332159367645
MENKES DISEASE	0.01282051	1.2328332159367645
SCLERODERMA	0.01282051	1.2328332159367645
CAFFEY DISEASE	0.01282051	1.2328332159367645
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.012698532	1.2211036880152126
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.012698532	1.2211036880152126
WILLIAMS SYNDROME	0.01266023	1.2174205289336464
TUBEROUS SCLEROSIS-1	0.01266023	1.2174205289336464
TUBEROUS SCLEROSIS 2; TSC2	0.01266023	1.2174205289336464
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.012530644	1.20495940803281
DISTAL MONOSOMY 10Q	0.012520344000000001	1.2039689496092256
ROBERTS SYNDROME	0.012520344000000001	1.2039689496092256
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.012469478	1.1990776235729104
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.012451940000000002	1.1973911517444809
GMS SYNDROME	0.012451940000000002	1.1973911517444809
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012450353999999999	1.197238640379451
SECKEL SYNDROME 9; SCKL9	0.012450353999999999	1.197238640379451
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012450353999999999	1.197238640379451
NETHERTON SYNDROME; NETH	0.012450353999999999	1.197238640379451
48,XYYY SYNDROME	0.012450353999999999	1.197238640379451
BARDET-BIEDL SYNDROME 1; BBS1	0.012450353999999999	1.197238640379451
NETHERTON SYNDROME	0.012450353999999999	1.197238640379451
GAUCHER DISEASE	0.01241883	1.194207260637211
CARTILAGE-HAIR HYPOPLASIA	0.012417870000000001	1.1941149460656924
ANGELMAN SYNDROME	0.012343360000000001	1.186949989061685
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01234188	1.186807670763927
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.01234188	1.186807670763927
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.012329389999999999	1.1856066197240658
CYSTINOSIS	0.012284650000000001	1.1813043760472537
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.012284650000000001	1.1813043760472537
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.012284650000000001	1.1813043760472537
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.012284650000000001	1.1813043760472537
TOWNES-BROCKS SYNDROME	0.012284650000000001	1.1813043760472537
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.012267082000000002	1.179615019388464
JOUBERT SYNDROME 26	0.012145392	1.1679131858383678
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.012145392	1.1679131858383678
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.012145392	1.1679131858383678
2P15P16.1 MICRODELETION SYNDROME	0.012120772	1.165545701722965
ADENYLOSUCCINASE DEFICIENCY	0.012120772	1.165545701722965
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.012120772	1.165545701722965
MOEBIUS SYNDROME; MBS	0.01198509	1.1524983832929858
ALAGILLE SYNDROME	0.011941680000000001	1.1483240337621314
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	1.1447776156396268
DUBOWITZ SYNDROME	0.011904799999999998	1.1447776156396268
IMMUNODEFICIENCY 58; IMD58	0.011904799999999998	1.1447776156396268
CHILBLAIN LUPUS	0.011904799999999998	1.1447776156396268
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	1.1447776156396268
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.011904799999999998	1.1447776156396268
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	1.1447776156396268
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	1.1447776156396268
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	1.1447776156396268
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	1.1447776156396268
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	1.1447776156396268
47,XYY SYNDROME	0.011904799999999998	1.1447776156396268
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	1.1447776156396268
ICHTHYOSIS VULGARIS	0.011904799999999998	1.1447776156396268
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	1.1447776156396268
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	1.1447776156396268
YAO SYNDROME	0.011904799999999998	1.1447776156396268
CARCINOID SYNDROME	0.011904799999999998	1.1447776156396268
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	1.1447776156396268
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	1.1447776156396268
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	1.1447776156396268
MYOTONIA PERMANENS	0.011904799999999998	1.1447776156396268
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	1.1447776156396268
BERNARD-SOULIER SYNDROME	0.011904799999999998	1.1447776156396268
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	1.1447776156396268
DERMATITIS, ATOPIC	0.011904799999999998	1.1447776156396268
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.011904799999999998	1.1447776156396268
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.01190476	1.144773769199147
LOEYS-DIETZ SYNDROME 5	0.01190476	1.144773769199147
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.011789932000000001	1.1337317925133843
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.011789932000000001	1.1337317925133843
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.011789932000000001	1.1337317925133843
SMITH-LEMLI-OPITZ SYNDROME	0.011636384	1.1189664614430401
INFANTILE SIALIC ACID STORAGE DISEASE	0.011614032	1.11681707050285
KAGAMI-OGATA SYNDROME	0.011614032	1.11681707050285
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011599838	1.1154521610985433
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.011599838	1.1154521610985433
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.011575218	1.1130846769831404
SIALURIA	0.011544002	1.1100829148325955
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.011507940000000001	1.106615156417906
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.011507940000000001	1.106615156417906
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.011507940000000001	1.106615156417906
LIG4 SYNDROME	0.011438544	1.0999419668292587
FUCOSIDOSIS	0.011438544	1.0999419668292587
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.011437048	1.099798109955309
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.011305544	1.0871525522334597
WEBB-DATTANI SYNDROME; WEDAS	0.011183854	1.0754507186833633
PALLISTER-HALL SYNDROME	0.011183854	1.0754507186833633
SILVER-RUSSELL SYNDROME; SRS	0.011183854	1.0754507186833633
XQ21 MICRODELETION SYNDROME	0.011183854	1.0754507186833633
SEPTOOPTIC DYSPLASIA	0.011183854	1.0754507186833633
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.011159234	1.0730832345679606
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.011159234	1.0730832345679606
6Q16 MICRODELETION SYNDROME	0.011159234	1.0730832345679606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.011159234	1.0730832345679606
2Q32Q33 MICRODELETION SYNDROME	0.011159234	1.0730832345679606
MOEBIUS SYNDROME	0.01109083	1.0665054367032156
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.01109083	1.0665054367032156
CHRISTIANSON SYNDROME	0.01109083	1.0665054367032156
GOLDENHAR SYNDROME	0.01109083	1.0665054367032156
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.011068478	1.0643560457630254
INFANTILE REFSUM DISEASE	0.011021064	1.0597966675401291
KLEEFSTRA SYNDROME	0.010828394	1.04126932535838
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.010828394	1.04126932535838
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.010783654	1.0369670816815675
WOLFRAM SYNDROME	0.01071525	1.030389283816823
AICARDI SYNDROME	0.01071525	1.030389283816823
CINCA SYNDROME	0.010652494	1.0243546033478454
CONGENITAL TOXOPLASMOSIS	0.010652494	1.0243546033478454
PEDIATRIC-ONSET GRAVES DISEASE	0.010652494	1.0243546033478454
WIEDEMANN-STEINER SYNDROME	0.0106383	1.022989693943539
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0106383	1.022989693943539
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0106383	1.022989693943539
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.0106383	1.022989693943539
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0106383	1.022989693943539
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0106383	1.022989693943539
PITUITARY APOPLEXY	0.0106383	1.022989693943539
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0106383	1.022989693943539
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0106383	1.022989693943539
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0106383	1.022989693943539
ACROOTOOCULAR SYNDROME	0.0106383	1.022989693943539
EEC SYNDROME	0.0106383	1.022989693943539
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0106383	1.022989693943539
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.0106383	1.022989693943539
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.0106383	1.022989693943539
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0106383	1.022989693943539
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0106383	1.022989693943539
PITUICYTOMA	0.0106383	1.022989693943539
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0106383	1.022989693943539
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0106383	1.022989693943539
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0106383	1.022989693943539
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0106383	1.022989693943539
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0106383	1.022989693943539
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.0106383	1.022989693943539
BOOMERANG DYSPLASIA	0.0106383	1.022989693943539
BONNEMANN-MEINECKE-REICH SYNDROME	0.0106383	1.022989693943539
RHYNS SYNDROME; RHYNS	0.0106383	1.022989693943539
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0106383	1.022989693943539
WILLIAMS-BEUREN SYNDROME; WBS	0.010628098	1.0220086592991304
CHIME SYNDROME	0.01061368	1.0206222098281361
PITT-HOPKINS-LIKE SYNDROME	0.01061368	1.0206222098281361
MOMO SYNDROME	0.01061368	1.0206222098281361
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01061368	1.0206222098281361
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01061368	1.0206222098281361
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010601628	1.0194632773115302
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.010582464	1.0176204476775914
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.01047551	1.0073356428003049
PFAPA SYNDROME	0.01047551	1.0073356428003049
SHWACHMAN-DIAMOND SYNDROME	0.010353532	0.995606114878753
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.010353532	0.995606114878753
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01028284	0.9888083006185556
3P25.3 MICRODELETION SYNDROME	0.01028284	0.9888083006185556
MENTAL RETARDATION, X-LINKED 90	0.010279022	0.9884411578747454
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010279022	0.9884411578747454
WEAVER SYNDROME	0.010279022	0.9884411578747454
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.010279022	0.9884411578747454
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.010279022	0.9884411578747454
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.010279022	0.9884411578747454
KOOLEN-DE VRIES SYNDROME	0.010212114000000001	0.9820072168839505
CONGENITAL HYPOTHYROIDISM	0.010212114000000001	0.9820072168839505
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01010694	0.9718935786080213
GAUCHER DISEASE, PERINATAL LETHAL	0.01010694	0.9718935786080213
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.01010694	0.9718935786080213
DISTAL MONOSOMY 17Q	0.01010694	0.9718935786080213
WILSON DISEASE	0.01003691	0.9651594229377669
GAPO SYNDROME; GAPOS	0.01003691	0.9651594229377669
ZIMMERMANN-LABAND SYNDROME	0.01003691	0.9651594229377669
EMANUEL SYNDROME	0.009910452	0.9529990936824618
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009910452	0.9529990936824618
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	0.9529990936824618
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.009910452	0.9529990936824618
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.009910452	0.9529990936824618
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009910452	0.9529990936824618
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.009910452	0.9529990936824618
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009910452	0.9529990936824618
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.009840422	0.9462649380122077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.009840422	0.9462649380122077
CK SYNDROME	0.009840422	0.9462649380122077
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.009840422	0.9462649380122077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009840422	0.9462649380122077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.009840422	0.9462649380122077
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.009840422	0.9462649380122077
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.009840422	0.9462649380122077
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.009840422	0.9462649380122077
ZTTK SYNDROME; ZTTKS	0.009840422	0.9462649380122077
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009840422	0.9462649380122077
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009840422	0.9462649380122077
JABERI-ELAHI SYNDROME; JABELS	0.009840422	0.9462649380122077
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.009840422	0.9462649380122077
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009840422	0.9462649380122077
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.009807978	0.9431450901389286
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.009734964	0.9361239900088709
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.009733468	0.9359801331349211
ALLAN-HERNDON-DUDLEY SYNDROME	0.009666560000000001	0.9295461921441261
COCKAYNE SYNDROME A; CSA	0.00964009	0.9270008101565261
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00964009	0.9270008101565261
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00964009	0.9270008101565261
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00964009	0.9270008101565261
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00964009	0.9270008101565261
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.009443602	0.9081063252309667
OROFACIODIGITAL SYNDROME XIV; OFD14	0.009443602	0.9081063252309667
CHROMOSOME 16Q22 DELETION SYNDROME	0.009443602	0.9081063252309667
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.009443602	0.9081063252309667
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.009443602	0.9081063252309667
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009443602	0.9081063252309667
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009443602	0.9081063252309667
HEART AND BRAIN MALFORMATION SYNDROME	0.009443602	0.9081063252309667
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.009443602	0.9081063252309667
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.009443602	0.9081063252309667
COFFIN-SIRIS SYNDROME 2; CSS2	0.009443602	0.9081063252309667
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.009391994	0.9031436477237486
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.009391994	0.9031436477237486
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.009391994	0.9031436477237486
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.009391994	0.9031436477237486
CHÉDIAK-HIGASHI SYNDROME	0.009391994	0.9031436477237486
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.009391994	0.9031436477237486
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.009376528	0.9016564215121801
NEMALINE MYOPATHY 10	0.009364898	0.9005380689426374
YUNIS-VARON SYNDROME	0.009364898	0.9005380689426374
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.9005380689426374
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.9005380689426374
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.8959786907197411
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.8959786907197411
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.8959786907197411
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.8959786907197411
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.8959786907197411
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.8959786907197411
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.8959786907197411
ARGININEMIA	0.009317484000000001	0.8959786907197411
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009317484000000001	0.8959786907197411
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.8959786907197411
LANDAU-KLEFFNER SYNDROME	0.009317484000000001	0.8959786907197411
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.8959786907197411
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.8959786907197411
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.8959786907197411
NEMALINE MYOPATHY 7; NEM7	0.009294868	0.8938039132723832
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009294868	0.8938039132723832
GIANT AXONAL NEUROPATHY	0.009294868	0.8938039132723832
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.009294868	0.8938039132723832
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.009294868	0.8938039132723832
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.009294868	0.8938039132723832
WARBURG MICRO SYNDROME 1	0.009294868	0.8938039132723832
LATERAL MENINGOCELE SYNDROME	0.009294868	0.8938039132723832
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.009294868	0.8938039132723832
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.009294868	0.8938039132723832
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.009294868	0.8938039132723832
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.009291384	0.8934688883065804
MACROCEPHALY/AUTISM SYNDROME	0.009291384	0.8934688883065804
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.009291384	0.8934688883065804
HALLERMANN-STREIFF SYNDROME	0.00918941	0.8836629652690464
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009127102000000002	0.8776713649334446
ANGELMAN SYNDROME	0.009127102000000002	0.8776713649334446
CHROMOSOME 1P36 DELETION SYNDROME	0.009127102000000002	0.8776713649334446
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	0.8605366265274577
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.008948914	0.8605366265274577
TYSHCHENKO SYNDROME	0.008948914	0.8605366265274577
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008948914	0.8605366265274577
COSTELLO SYNDROME; CSTLO	0.008948914	0.8605366265274577
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008948914	0.8605366265274577
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.8605366265274577
FG SYNDROME TYPE 1	0.008948914	0.8605366265274577
KAGAMI-OGATA SYNDROME	0.008948914	0.8605366265274577
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.008948914	0.8605366265274577
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.8605366265274577
VASCULAR EHLERS-DANLOS SYNDROME	0.008948914	0.8605366265274577
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.008948914	0.8605366265274577
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.008948914	0.8605366265274577
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.008898048	0.8556453004911424
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.008898048	0.8556453004911424
ACROCALLOSAL SYNDROME; ACLS	0.008898048	0.8556453004911424
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008898048	0.8556453004911424
3MC SYNDROME 2	0.008878884	0.8538024708572033
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.008878884	0.8538024708572033
OKAMOTO SYNDROME	0.008878884	0.8538024708572033
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008878884	0.8538024708572033
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.008878884	0.8538024708572033
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.008878884	0.8538024708572033
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.008878884	0.8538024708572033
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008878884	0.8538024708572033
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.008878884	0.8538024708572033
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.008878884	0.8538024708572033
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.008878884	0.8538024708572033
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.008878884	0.8538024708572033
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.008878884	0.8538024708572033
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00884644	0.8506826229839244
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00884644	0.8506826229839244
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.00884644	0.8506826229839244
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.8435176659799167
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.8435176659799167
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.8435176659799167
DIENCEPHALIC SYNDROME	0.00877193	0.8435176659799167
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.8435176659799167
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.8435176659799167
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.8435176659799167
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.8435176659799167
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.8435176659799167
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8435176659799167
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.8435176659799167
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.8435176659799167
SNEDDON SYNDROME	0.00877193	0.8435176659799167
HISTIDINEMIA	0.00877193	0.8435176659799167
RHEUMATIC FEVER	0.00877193	0.8435176659799167
LOCKED-IN SYNDROME	0.00877193	0.8435176659799167
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.8435176659799167
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.8435176659799167
PINEOBLASTOMA	0.00877193	0.8435176659799167
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.8435176659799167
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00877193	0.8435176659799167
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.8435176659799167
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.8435176659799167
HUNTINGTON DISEASE	0.00877193	0.8435176659799167
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.8435176659799167
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.8435176659799167
KEIPERT SYNDROME	0.00877193	0.8435176659799167
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.8435176659799167
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	0.8435176659799167
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.8435176659799167
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.8435176659799167
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.8435176659799167
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.8435176659799167
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.8435176659799167
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.8435176659799167
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.8435176659799167
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.8435176659799167
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.8435176659799167
CORTICOBASAL SYNDROME	0.00877193	0.8435176659799167
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.8435176659799167
HISTIDINEMIA	0.00877193	0.8435176659799167
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.8435176659799167
1Q41Q42 MICRODELETION SYNDROME	0.00877193	0.8435176659799167
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.8435176659799167
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.8435176659799167
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.8435176659799167
NANCE-HORAN SYNDROME	0.00877193	0.8435176659799167
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8435176659799167
BREATH-HOLDING SPELLS	0.00877193	0.8435176659799167
LESCH-NYHAN SYNDROME	0.00877193	0.8435176659799167
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.8435176659799167
MILROY DISEASE	0.00877193	0.8435176659799167
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.8435176659799167
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.8435176659799167
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.8435176659799167
RETT SYNDROME	0.00874583	0.8410078635667559
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00874583	0.8410078635667559
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.008649952	0.8317881380583649
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.008649952	0.8317881380583649
TRICHOTHIODYSTROPHY	0.008649952	0.8317881380583649
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.008649952	0.8317881380583649
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.008649952	0.8317881380583649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.008549342	0.8221133786411967
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.008549342	0.8221133786411967
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.008549342	0.8221133786411967
GABRIELE-DE VRIES SYNDROME; GADEVS	0.008482064000000001	0.8156438580759625
16P11.2P12.2 MICRODELETION SYNDROME	0.008482064000000001	0.8156438580759625
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.008482064000000001	0.8156438580759625
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.008482064000000001	0.8156438580759625
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.8156438580759625
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.008482064000000001	0.8156438580759625
MENTAL RETARDATION, X-LINKED 104; MRX104	0.008482064000000001	0.8156438580759625
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008482064000000001	0.8156438580759625
6Q25 MICRODELETION SYNDROME	0.008482064000000001	0.8156438580759625
FETAL HYDANTOIN SYNDROME	0.008482064000000001	0.8156438580759625
CATEL-MANZKE SYNDROME; CATMANS	0.008482064000000001	0.8156438580759625
OTOPALATODIGITAL SYNDROME TYPE 2	0.008482064000000001	0.8156438580759625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.008482064000000001	0.8156438580759625
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.008482064000000001	0.8156438580759625
COG5-CDG	0.00841499	0.8091939543571757
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8080756017876332
EBSTEIN MALFORMATION	0.00840336	0.8080756017876332
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.8080756017876332
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8080756017876332
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.8080756017876332
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.8080756017876332
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8080756017876332
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.8080756017876332
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.8080756017876332
RENAL TUBULAR DYSGENESIS	0.00840336	0.8080756017876332
RETINOPATHY OF PREMATURITY	0.00840336	0.8080756017876332
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8080756017876332
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8080756017876332
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8080756017876332
VACTERL/VATER ASSOCIATION	0.00840336	0.8080756017876332
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8080756017876332
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8080756017876332
FATCO SYNDROME	0.00840336	0.8080756017876332
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8080756017876332
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8080756017876332
PEMPHIGOID GESTATIONIS	0.00840336	0.8080756017876332
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8080756017876332
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.8080756017876332
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.8080756017876332
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.8080756017876332
HYDROLETHALUS	0.00840336	0.8080756017876332
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.8080756017876332
OMPHALOCELE	0.00840336	0.8080756017876332
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.8080756017876332
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.8080756017876332
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.8080756017876332
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8080756017876332
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8080756017876332
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.8080756017876332
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8080756017876332
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.8080756017876332
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8080756017876332
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	0.8080756017876332
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8080756017876332
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8080756017876332
HEC SYNDROME	0.00840336	0.8080756017876332
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8080756017876332
SCHISIS ASSOCIATION	0.00840336	0.8080756017876332
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8080756017876332
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.8080756017876332
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8080756017876332
MUCKLE-WELLS SYNDROME	0.008370250000000001	0.8048917106803632
GAUCHER DISEASE TYPE 3	0.008370250000000001	0.8048917106803632
CYSTINOSIS, NEPHROPATHIC; CTNS	0.008370250000000001	0.8048917106803632
NIEMANN-PICK DISEASE TYPE B	0.008370250000000001	0.8048917106803632
ACROOSTEOLYSIS DOMINANT TYPE	0.008370250000000001	0.8048917106803632
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.008370250000000001	0.8048917106803632
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00833333	0.8013414461173788
STICKLER SYNDROME, TYPE II	0.00833333	0.8013414461173788
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00833333	0.8013414461173788
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00833333	0.8013414461173788
OSTEOGENESIS IMPERFECTA, TYPE I	0.00833333	0.8013414461173788
MEIER-GORLIN SYNDROME 2; MGORS2	0.00833333	0.8013414461173788
RIN2 SYNDROME	0.00833333	0.8013414461173788
MARFANOID HYPERMOBILITY SYNDROME	0.00833333	0.8013414461173788
BRITTLE CORNEA SYNDROME 2; BCS2	0.00833333	0.8013414461173788
MEESTER-LOEYS SYNDROME; MRLS	0.00833333	0.8013414461173788
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00833333	0.8013414461173788
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00833333	0.8013414461173788
BAZEX SYNDROME; BZX	0.00833333	0.8013414461173788
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00833333	0.8013414461173788
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00833333	0.8013414461173788
15Q OVERGROWTH SYNDROME	0.00833333	0.8013414461173788
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00833333	0.8013414461173788
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00833333	0.8013414461173788
NEONATAL MARFAN SYNDROME	0.00833333	0.8013414461173788
MACS SYNDROME	0.00833333	0.8013414461173788
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00833333	0.8013414461173788
VESICOURETERAL REFLUX 8; VUR8	0.00833333	0.8013414461173788
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00833333	0.8013414461173788
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00833333	0.8013414461173788
ODONTOCHONDRODYSPLASIA; ODCD	0.00833333	0.8013414461173788
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00833333	0.8013414461173788
OSTEOGENESIS IMPERFECTA, TYPE V	0.00833333	0.8013414461173788
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00833333	0.8013414461173788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.008283098	0.7965110861626706
SHUKLA-VERNON SYNDROME; SHUVER	0.008218502	0.7902994694316163
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.008218502	0.7902994694316163
RING CHROMOSOME 22 SYNDROME	0.008218502	0.7902994694316163
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.008218502	0.7902994694316163
CHROMOSOME 16P13.2 DELETION SYNDROME	0.008218502	0.7902994694316163
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008218502	0.7902994694316163
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.008218502	0.7902994694316163
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.008218502	0.7902994694316163
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.008218502	0.7902994694316163
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.008218502	0.7902994694316163
OGDEN SYNDROME	0.008218502	0.7902994694316163
KLEEFSTRA SYNDROME 2; KLEFS2	0.008218502	0.7902994694316163
XQ25 MICRODUPLICATION SYNDROME	0.008218502	0.7902994694316163
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008218502	0.7902994694316163
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008218502	0.7902994694316163
LUSCAN-LUMISH SYNDROME; LLS	0.008218502	0.7902994694316163
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.008218502	0.7902994694316163
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.008218502	0.7902994694316163
HYPERPROLINEMIA, TYPE I	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008218502	0.7902994694316163
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.008218502	0.7902994694316163
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008218502	0.7902994694316163
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.008218502	0.7902994694316163
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008218502	0.7902994694316163
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.008218502	0.7902994694316163
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008218502	0.7902994694316163
TETRASOMY 9P	0.008218502	0.7902994694316163
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.008218502	0.7902994694316163
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.008218502	0.7902994694316163
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.008218502	0.7902994694316163
PETERS PLUS SYNDROME	0.008165564	0.7852088977784402
CORNELIA DE LANGE SYNDROME 3	0.008165564	0.7852088977784402
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.008104398	0.7793271133185405
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.008104398	0.7793271133185405
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.008104398	0.7793271133185405
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.008003788	0.7696523539013723
CYCLIC VOMITING SYNDROME	0.008003788	0.7696523539013723
ALG13-CDG	0.008003788	0.7696523539013723
RING CHROMOSOME 13 SYNDROME	0.008003788	0.7696523539013723
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.008003788	0.7696523539013723
TRISOMY 18P	0.00793651	0.763182833336138
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00793651	0.763182833336138
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.763182833336138
ACROCRANIOFACIAL DYSOSTOSIS	0.00793651	0.763182833336138
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00793651	0.763182833336138
AASE-SMITH SYNDROME I	0.00793651	0.763182833336138
SECKEL SYNDROME 1; SCKL1	0.00793651	0.763182833336138
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.763182833336138
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.763182833336138
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00793651	0.763182833336138
MAXILLOFACIAL DYSOSTOSIS	0.00793651	0.763182833336138
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00793651	0.763182833336138
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.763182833336138
BRANCHIO-OCULO-FACIAL SYNDROME	0.00793651	0.763182833336138
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.763182833336138
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.763182833336138
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.00793651	0.763182833336138
184705 STEINFELD SYNDROME	0.00793651	0.763182833336138
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.763182833336138
KENNERKNECHT SYNDROME	0.00793651	0.763182833336138
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00793651	0.763182833336138
3MC SYNDROME 3	0.00793651	0.763182833336138
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.763182833336138
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00793651	0.763182833336138
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00793651	0.763182833336138
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.763182833336138
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.763182833336138
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00793651	0.763182833336138
AASE-SMITH SYNDROME	0.00793651	0.763182833336138
BARBER-SAY SYNDROME	0.00793651	0.763182833336138
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00793651	0.763182833336138
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.763182833336138
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00793651	0.763182833336138
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.763182833336138
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00793651	0.763182833336138
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00793651	0.763182833336138
SIMOSA CRANIOFACIAL SYNDROME	0.00793651	0.763182833336138
FOCAL DERMAL HYPOPLASIA; FDH	0.00793651	0.763182833336138
HYDROLETHALUS SYNDROME 1	0.00793651	0.763182833336138
PELVISCAPULAR DYSPLASIA	0.00793651	0.763182833336138
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.763182833336138
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.763182833336138
KEIPERT SYNDROME; KPTS	0.00793651	0.763182833336138
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.00793651	0.763182833336138
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.763182833336138
BRANCHIOOTIC SYNDROME 2	0.00793651	0.763182833336138
MOSAIC TRISOMY 1	0.00793651	0.763182833336138
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.763182833336138
OCULOSKELETODENTAL SYNDROME; OCSKD	0.007867114	0.7565096437474907
SYNDROMIC DIARRHEA	0.007867114	0.7565096437474907
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007688414	0.7393256709033605
PELGER-HUET ANOMALY; PHA	0.007688414	0.7393256709033605
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.007688414	0.7393256709033605
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007688414	0.7393256709033605
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.007688414	0.7393256709033605
SAUL-WILSON SYNDROME; SWILS	0.007688414	0.7393256709033605
ROTHMUND-THOMSON SYNDROME	0.007688414	0.7393256709033605
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.007672948000000001	0.7378384446917919
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.007672948000000001	0.7378384446917919
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.007672948000000001	0.7378384446917919
MICROPHTHALMIA, SYNDROMIC 1	0.007672948000000001	0.7378384446917919
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.007628208000000001	0.7335362010149795
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.007628208000000001	0.7335362010149795
MARTSOLF SYNDROME	0.00762001	0.7327478730386158
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00762001	0.7327478730386158
15Q14 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.7296509114861924
17Q12 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
AUSTRALIA ANTIGEN	0.007587804	0.7296509114861924
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.007587804	0.7296509114861924
2Q37 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
CLASSIC PHENYLKETONURIA	0.007587804	0.7296509114861924
17P11.2 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
15Q11Q13 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
16P13.11 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.007587804	0.7296509114861924
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.007587804	0.7296509114861924
15Q13.3 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
MENTAL RETARDATION, X-LINKED 9	0.007587804	0.7296509114861924
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.007587804	0.7296509114861924
COWDEN SYNDROME	0.007587804	0.7296509114861924
3Q29 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.007587804	0.7296509114861924
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.007587804	0.7296509114861924
1Q21.1 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.007587804	0.7296509114861924
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007587804	0.7296509114861924
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007587804	0.7296509114861924
1Q21.1 MICRODUPLICATION SYNDROME	0.007587804	0.7296509114861924
10Q22.3Q23.3 MICRODELETION SYNDROME	0.007587804	0.7296509114861924
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.007587804	0.7296509114861924
WHIPPLE DISEASE	0.0073215599999999995	0.7040486190076664
AA AMYLOIDOSIS	0.0073215599999999995	0.7040486190076664
BETA-THALASSEMIA INTERMEDIA	0.0073215599999999995	0.7040486190076664
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0073215599999999995	0.7040486190076664
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0073215599999999995	0.7040486190076664
ISOLATED BILIARY ATRESIA	0.0073215599999999995	0.7040486190076664
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007259252000000001	0.6980570186720645
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.007259252000000001	0.6980570186720645
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.007259252000000001	0.6980570186720645
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.007259252000000001	0.6980570186720645
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.007259252000000001	0.6980570186720645
NIEMANN-PICK DISEASE, TYPE A	0.007259252000000001	0.6980570186720645
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	0.6978370022766119
FRIED SYNDROME	0.007256964	0.6978370022766119
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.007256964	0.6978370022766119
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.007256964	0.6978370022766119
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007256964	0.6978370022766119
DISTAL 16P11.2 MICRODELETION SYNDROME	0.007256964	0.6978370022766119
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.007256964	0.6978370022766119
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	0.6978370022766119
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	0.6978370022766119
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.6978370022766119
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	0.6978370022766119
MONOSOMY 22Q13.3	0.007256964	0.6978370022766119
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.6978370022766119
PITT-HOPKINS SYNDROME	0.007256964	0.6978370022766119
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.007256964	0.6978370022766119
DISTAL MONOSOMY 15Q	0.007256964	0.6978370022766119
PRADER-WILLI-LIKE SYNDROME	0.007256964	0.6978370022766119
MYOCLONIC-ASTASTIC EPILEPSY	0.007256964	0.6978370022766119
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.6978370022766119
OBESITY DUE TO SIM1 DEFICIENCY	0.007256964	0.6978370022766119
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.6978370022766119
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007256964	0.6978370022766119
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.007256964	0.6978370022766119
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.007256964	0.6978370022766119
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.007256964	0.6978370022766119
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.007256964	0.6978370022766119
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	0.6978370022766119
HSD10 DISEASE	0.007256964	0.6978370022766119
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	0.6978370022766119
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	0.6978370022766119
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.6978370022766119
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	0.6978370022766119
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.6978370022766119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.007212224000000001	0.6935347585997995
AARSKOG-SCOTT SYNDROME	0.007212224000000001	0.6935347585997995
RUVALCABA SYNDROME	0.007212224000000001	0.6935347585997995
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.007212224000000001	0.6935347585997995
CRANIOPHARYNGIOMA	0.007212224000000001	0.6935347585997995
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.007212224000000001	0.6935347585997995
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.007212224000000001	0.6935347585997995
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007212224000000001	0.6935347585997995
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.007212224000000001	0.6935347585997995
MICRO SYNDROME	0.007212224000000001	0.6935347585997995
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00714286	0.6868646461635362
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00714286	0.6868646461635362
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00714286	0.6868646461635362
AREGENERATIVE ANEMIA	0.00714286	0.6868646461635362
DIAMOND-BLACKFAN ANEMIA 18; DBA18	0.00714286	0.6868646461635362
TOXIC EPIDERMAL NECROLYSIS	0.00714286	0.6868646461635362
IMMUNODEFICIENCY 50; IMD50	0.00714286	0.6868646461635362
HERMANSKY-PUDLAK SYNDROME	0.00714286	0.6868646461635362
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00714286	0.6868646461635362
RETINAL VENOUS BEADING	0.00714286	0.6868646461635362
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00714286	0.6868646461635362
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00714286	0.6868646461635362
BARE LYMPHOCYTE SYNDROME, TYPE II	0.00714286	0.6868646461635362
WISKOTT-ALDRICH SYNDROME	0.00714286	0.6868646461635362
THROMBOCYTOPENIA 5; THC5	0.00714286	0.6868646461635362
CYCLIC NEUTROPENIA	0.00714286	0.6868646461635362
ADULT IDIOPATHIC NEUTROPENIA	0.00714286	0.6868646461635362
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.6868646461635362
FELTY SYNDROME	0.00714286	0.6868646461635362
LAZY LEUKOCYTE SYNDROME	0.00714286	0.6868646461635362
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.00714286	0.6868646461635362
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00714286	0.6868646461635362
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00714286	0.6868646461635362
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00714286	0.6868646461635362
TRANSCOBALAMIN DEFICIENCY	0.00714286	0.6868646461635362
CYCLIC NEUTROPENIA	0.00714286	0.6868646461635362
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00714286	0.6868646461635362
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.00714286	0.6868646461635362
REFRACTORY ANEMIA	0.00714286	0.6868646461635362
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.00714286	0.6868646461635362
THROMBOCYTOPENIA, CYCLIC	0.00714286	0.6868646461635362
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00714286	0.6868646461635362
NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	0.00714286	0.6868646461635362
DIAMOND-BLACKFAN ANEMIA 8	0.00714286	0.6868646461635362
WHIM SYNDROME	0.00714286	0.6868646461635362
HEMOCHROMATOSIS, TYPE 3; HFE3	0.00714286	0.6868646461635362
IDIOPATHIC APLASTIC ANEMIA	0.00714286	0.6868646461635362
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.00714286	0.6868646461635362
GLUTATHIONE SYNTHETASE DEFICIENCY	0.00714286	0.6868646461635362
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00714286	0.6868646461635362
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.6868646461635362
IMMUNODEFICIENCY 55; IMD55	0.00714286	0.6868646461635362
BARTH SYNDROME; BTHS	0.00714286	0.6868646461635362
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00714286	0.6868646461635362
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.00714286	0.6868646461635362
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00714286	0.6868646461635362
FANCONI ANEMIA	0.00714286	0.6868646461635362
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00714286	0.6868646461635362
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00714286	0.6868646461635362
IMMUNODEFICIENCY 21; IMD21	0.00714286	0.6868646461635362
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00714286	0.6868646461635362
DIAMOND-BLACKFAN ANEMIA 4	0.00714286	0.6868646461635362
ATAXIA-PANCYTOPENIA SYNDROME	0.00714286	0.6868646461635362
LETTERER-SIWE DISEASE	0.00714286	0.6868646461635362
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00714286	0.6868646461635362
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00714286	0.6868646461635362
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.00714286	0.6868646461635362
IMMUNODEFICIENCY 46; IMD46	0.00714286	0.6868646461635362
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.00714286	0.6868646461635362
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007125072	0.685154134082107
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007125072	0.685154134082107
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.007125072	0.685154134082107
PERIPHERAL HYPOTHYROIDISM	0.007125072	0.685154134082107
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00704225	0.677189886746368
NANCE-HORAN SYNDROME	0.00704225	0.677189886746368
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.677189886746368
AUTISM	0.00704225	0.677189886746368
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00704225	0.677189886746368
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00704225	0.677189886746368
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00704225	0.677189886746368
EARLY-ONSET SCHIZOPHRENIA	0.00704225	0.677189886746368
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00704225	0.677189886746368
HYPERLEXIA	0.00704225	0.677189886746368
FRAGILE X SYNDROME	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00704225	0.677189886746368
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00704225	0.677189886746368
FRAGILE X MENTAL RETARDATION SYNDROME	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00704225	0.677189886746368
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00704225	0.677189886746368
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.00704225	0.677189886746368
4Q21 MICRODELETION SYNDROME	0.00704225	0.677189886746368
BRUNNER SYNDROME; BRNRS	0.00704225	0.677189886746368
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.00704225	0.677189886746368
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.00704225	0.677189886746368
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, 18	0.00704225	0.677189886746368
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.677189886746368
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00704225	0.677189886746368
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00704225	0.677189886746368
16Q24.3 MICRODELETION SYNDROME	0.00704225	0.677189886746368
CHROMOSOME 17Q12 DELETION SYNDROME	0.00704225	0.677189886746368
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00704225	0.677189886746368
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.00704225	0.677189886746368
RECESSIVE X-LINKED ICHTHYOSIS	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00704225	0.677189886746368
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.677189886746368
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00704225	0.677189886746368
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.006782102	0.6521737917969849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.006782102	0.6521737917969849
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.006713698000000001	0.6455959939322402
LIVER FAILURE, INFANTILE, TRANSIENT	0.006713698000000001	0.6455959939322402
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.006713698000000001	0.6455959939322402
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.006713698000000001	0.6455959939322402
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.006713698000000001	0.6455959939322402
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.006713698000000001	0.6455959939322402
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.006713698000000001	0.6455959939322402
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.006713698000000001	0.6455959939322402
49,XXXYY SYNDROME	0.00671141	0.6453759775367875
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.6453759775367875
CHILDHOOD APRAXIA OF SPEECH	0.00671141	0.6453759775367875
XQ12-Q13.3 DUPLICATION SYNDROME	0.00671141	0.6453759775367875
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.6453759775367875
9Q21.13 MICRODELETION SYNDROME	0.00671141	0.6453759775367875
LENNOX-GASTAUT SYNDROME	0.00671141	0.6453759775367875
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00671141	0.6453759775367875
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.6453759775367875
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00671141	0.6453759775367875
2Q24 MICRODELETION SYNDROME	0.00671141	0.6453759775367875
RETT SYNDROME; RTT	0.00671141	0.6453759775367875
DRAVET SYNDROME	0.00671141	0.6453759775367875
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00671141	0.6453759775367875
HYPERTELORISM, TEEBI TYPE; TBHS	0.00671141	0.6453759775367875
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.6453759775367875
5Q14.3 MICRODELETION SYNDROME	0.00671141	0.6453759775367875
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00671141	0.6453759775367875
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00671141	0.6453759775367875
FRAXE INTELLECTUAL DISABILITY	0.00671141	0.6453759775367875
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00671141	0.6453759775367875
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00671141	0.6453759775367875
STURGE-WEBER SYNDROME	0.00671141	0.6453759775367875
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00671141	0.6453759775367875
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00671141	0.6453759775367875
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00671141	0.6453759775367875
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00671141	0.6453759775367875
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.6453759775367875
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00671141	0.6453759775367875
20Q13.33 MICRODELETION SYNDROME	0.00671141	0.6453759775367875
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00671141	0.6453759775367875
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00666667	0.6410737338599751
KALLMANN SYNDROME	0.00666667	0.6410737338599751
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00666667	0.6410737338599751
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00666667	0.6410737338599751
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00666667	0.6410737338599751
PREMATURE OVARIAN FAILURE 2B	0.00666667	0.6410737338599751
ACUTE ADRENAL INSUFFICIENCY	0.00666667	0.6410737338599751
PROLACTINOMA	0.00666667	0.6410737338599751
ATYPICAL WERNER SYNDROME	0.00666667	0.6410737338599751
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00666667	0.6410737338599751
ULNAR-MAMMARY SYNDROME; UMS	0.00666667	0.6410737338599751
OVARIAN DYSGENESIS 2; ODG2	0.00666667	0.6410737338599751
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00666667	0.6410737338599751
GEMIGNANI SYNDROME	0.00666667	0.6410737338599751
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00666667	0.6410737338599751
BLACKFAN-DIAMOND ANEMIA	0.00666667	0.6410737338599751
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00666667	0.6410737338599751
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00666667	0.6410737338599751
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00666667	0.6410737338599751
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00666667	0.6410737338599751
RUVALCABA SYNDROME	0.00666667	0.6410737338599751
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	0.6410737338599751
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00666667	0.6410737338599751
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00666667	0.6410737338599751
46,XX GONADAL DYSGENESIS	0.00666667	0.6410737338599751
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00666667	0.6410737338599751
H SYNDROME	0.00666667	0.6410737338599751
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00666667	0.6410737338599751
ADRENAL HYPOPLASIA, CONGENITAL	0.00666667	0.6410737338599751
ATAXIA-TELANGIECTASIA	0.00666667	0.6410737338599751
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00666667	0.6410737338599751
BIEMOND SYNDROME TYPE 2	0.00666667	0.6410737338599751
GITELMAN SYNDROME	0.00666667	0.6410737338599751
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00666667	0.6410737338599751
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00666667	0.6410737338599751
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00666667	0.6410737338599751
OVARIAN DYSGENESIS 7; ODG7	0.00666667	0.6410737338599751
46,XY PARTIAL GONADAL DYSGENESIS	0.00666667	0.6410737338599751
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.6410737338599751
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.00666667	0.6410737338599751
CAMURATI-ENGELMANN DISEASE	0.00666667	0.6410737338599751
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00666667	0.6410737338599751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00666667	0.6410737338599751
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00666667	0.6410737338599751
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00666667	0.6410737338599751
ANDROGEN INSENSITIVITY SYNDROME	0.00666667	0.6410737338599751
GITELMAN SYNDROME	0.00666667	0.6410737338599751
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00666667	0.6410737338599751
TSH-SECRETING PITUITARY ADENOMA	0.00666667	0.6410737338599751
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00666667	0.6410737338599751
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00666667	0.6410737338599751
ADDISON DISEASE	0.00666667	0.6410737338599751
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00666667	0.6410737338599751
INSULIN-RESISTANCE SYNDROME TYPE A	0.00666667	0.6410737338599751
ULNAR-MAMMARY SYNDROME	0.00666667	0.6410737338599751
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00666667	0.6410737338599751
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00666667	0.6410737338599751
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0065795179999999995	0.6326931093422826
JOHANSON-BLIZZARD SYNDROME; JBS	0.0065795179999999995	0.6326931093422826
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0065795179999999995	0.6326931093422826
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0065795179999999995	0.6326931093422826
GALACTOSEMIA	0.006297714	0.6055945515170602
ARGININOSUCCINIC ACIDURIA	0.006297714	0.6055945515170602
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.006297714	0.6055945515170602
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.006163534	0.5926916669271026
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006163534	0.5926916669271026
FAMILIAL THYROID DYSHORMONOGENESIS	0.006163534	0.5926916669271026
DIGEORGE SYNDROME; DGS	0.006163534	0.5926916669271026
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.006163534	0.5926916669271026
CUTIS LAXA	0.006163534	0.5926916669271026
AICARDI-GOUTIÈRES SYNDROME	0.006163534	0.5926916669271026
LYMPHEDEMA, HEREDITARY, III	0.006163534	0.5926916669271026
TOWNES-BROCKS SYNDROME 1; TBS1	0.006163534	0.5926916669271026
PRIMARY CONGENITAL HYPOTHYROIDISM	0.006163534	0.5926916669271026
PHACE SYNDROME	0.006163534	0.5926916669271026
THYROID HYPOPLASIA	0.006163534	0.5926916669271026
ATHYREOSIS	0.006163534	0.5926916669271026
RING CHROMOSOME 12 SYNDROME	0.006163534	0.5926916669271026
LIG4 SYNDROME	0.006163534	0.5926916669271026
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.006163534	0.5926916669271026
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.006163534	0.5926916669271026
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.006163534	0.5926916669271026
THYROID ECTOPIA	0.006163534	0.5926916669271026
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.006163534	0.5926916669271026
RABSON-MENDENHALL SYNDROME	0.006163534	0.5926916669271026
PERMANENT CONGENITAL HYPOTHYROIDISM	0.006163534	0.5926916669271026
NOONAN SYNDROME	0.00575216	0.5531335267772357
ISOLATED POLYCYSTIC LIVER DISEASE	0.00575216	0.5531335267772357
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00575216	0.5531335267772357
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00561798	0.5402306421872783
HAWKINSINURIA	0.00561798	0.5402306421872783
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00561798	0.5402306421872783
CONGENITAL MACROGLOSSIA	0.00561798	0.5402306421872783
ADIPOSIS DOLOROSA	0.00561798	0.5402306421872783
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00561798	0.5402306421872783
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00561798	0.5402306421872783
COWDEN SYNDROME 5; CWS5	0.00561798	0.5402306421872783
JUNG SYNDROME	0.00561798	0.5402306421872783
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00561798	0.5402306421872783
COWDEN SYNDROME 6; CWS6	0.00561798	0.5402306421872783
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00561798	0.5402306421872783
BANGSTAD SYNDROME	0.00561798	0.5402306421872783
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00561798	0.5402306421872783
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00561798	0.5402306421872783
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00561798	0.5402306421872783
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00561798	0.5402306421872783
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00561798	0.5402306421872783
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00561798	0.5402306421872783
ACERULOPLASMINEMIA	0.00561798	0.5402306421872783
CENANI-LENZ SYNDROME	0.00561798	0.5402306421872783
THYROID LYMPHOMA	0.00561798	0.5402306421872783
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00561798	0.5402306421872783
POEMS SYNDROME	0.00561798	0.5402306421872783
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00561798	0.5402306421872783
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00561798	0.5402306421872783
PRECOCIOUS PUBERTY, CENTRAL	0.00561798	0.5402306421872783
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00561798	0.5402306421872783
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00561798	0.5402306421872783
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00561798	0.5402306421872783
PENDRED SYNDROME	0.00561798	0.5402306421872783
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00561798	0.5402306421872783
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00561798	0.5402306421872783
CONGENITAL ATRANSFERRINEMIA	0.00561798	0.5402306421872783
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.00561798	0.5402306421872783
SUBCORNEAL PUSTULAR DERMATOSIS	0.00561798	0.5402306421872783
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.00561798	0.5402306421872783
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00561798	0.5402306421872783
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00561798	0.5402306421872783
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00561798	0.5402306421872783
GNE MYOPATHY	0.00561798	0.5402306421872783
METHIMAZOLE EMBRYOFETOPATHY	0.00561798	0.5402306421872783
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00561798	0.5402306421872783
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00561798	0.5402306421872783
ALEXANDER DISEASE	0.00561798	0.5402306421872783
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00561798	0.5402306421872783
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00561798	0.5402306421872783
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00561798	0.5402306421872783
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00561798	0.5402306421872783
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00561798	0.5402306421872783
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00561798	0.5402306421872783
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00561798	0.5402306421872783
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00561798	0.5402306421872783
FETAL IODINE SYNDROME	0.00561798	0.5402306421872783
MYXEDEMA	0.00561798	0.5402306421872783
ASCHER SYNDROME	0.00561798	0.5402306421872783
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.005555672000000001	0.5342390418516765
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.005555672000000001	0.5342390418516765
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.005555672000000001	0.5342390418516765
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005555672000000001	0.5342390418516765
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.005555672000000001	0.5342390418516765
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.005555672000000001	0.5342390418516765
SHASHI-PENA SYNDROME; SHAPNS	0.005555672000000001	0.5342390418516765
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.005555672000000001	0.5342390418516765
OROFACIODIGITAL SYNDROME TYPE 6	0.005555672000000001	0.5342390418516765
PEHO SYNDROME; PEHO	0.005555672000000001	0.5342390418516765
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.005555672000000001	0.5342390418516765
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005555672000000001	0.5342390418516765
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.005555672000000001	0.5342390418516765
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.005555672000000001	0.5342390418516765
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005555672000000001	0.5342390418516765
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.005555672000000001	0.5342390418516765
PYCNODYSOSTOSIS	0.00527501	0.5072502999021561
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.005078522	0.48835581497659686
DISTAL MONOSOMY 12Q	0.005078522	0.48835581497659686
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005078522	0.48835581497659686
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005078522	0.48835581497659686
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.005078522	0.48835581497659686
CRANIOSYNOSTOSIS 6; CRS6	0.005078522	0.48835581497659686
CRANIOFRONTONASAL SYNDROME; CFNS	0.005078522	0.48835581497659686
RECOMBINANT CHROMOSOME 8 SYNDROME	0.005078522	0.48835581497659686
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.005078522	0.48835581497659686
LARSEN-LIKE SYNDROME	0.005078522	0.48835581497659686
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.005078522	0.48835581497659686
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.005078522	0.48835581497659686
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.005078522	0.48835581497659686
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005078522	0.48835581497659686
NON-DISTAL MONOSOMY 20Q	0.005010118000000001	0.4817780171118521
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.005010118000000001	0.4817780171118521
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.005010118000000001	0.4817780171118521
MYOTONIC DYSTROPHY 1	0.005010118000000001	0.4817780171118521
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.005010118000000001	0.4817780171118521
NEMALINE MYOPATHY 4	0.005010118000000001	0.4817780171118521
OHDO SYNDROME	0.005010118000000001	0.4817780171118521
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.005010118000000001	0.4817780171118521
MAPLE SYRUP URINE DISEASE; MSUD	0.005010118000000001	0.4817780171118521
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.005010118000000001	0.4817780171118521
LISSENCEPHALY, X-LINKED, 2	0.005010118000000001	0.4817780171118521
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.005010118000000001	0.4817780171118521
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.005010118000000001	0.4817780171118521
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.005010118000000001	0.4817780171118521
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.005010118000000001	0.4817780171118521
DUBOWITZ SYNDROME	0.005010118000000001	0.4817780171118521
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.005010118000000001	0.4817780171118521
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005010118000000001	0.4817780171118521
3C SYNDROME	0.004594134000000001	0.4417765746966722
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.004594134000000001	0.4417765746966722
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004594134000000001	0.4417765746966722
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004594134000000001	0.4417765746966722
VICI SYNDROME	0.004594134000000001	0.4417765746966722
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.4417765746966722
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.004594134000000001	0.4417765746966722
AICARDI-GOUTIERES SYNDROME 5	0.004594134000000001	0.4417765746966722
COFFIN-SIRIS SYNDROME	0.004594134000000001	0.4417765746966722
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.4417765746966722
CANAVAN DISEASE	0.004594134000000001	0.4417765746966722
PETERS-PLUS SYNDROME; PTRPLS	0.004594134000000001	0.4417765746966722
HOLOPROSENCEPHALY	0.004594134000000001	0.4417765746966722
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004594134000000001	0.4417765746966722
WEAVER SYNDROME	0.004594134000000001	0.4417765746966722
JOUBERT SYNDROME	0.004594134000000001	0.4417765746966722
RUBINSTEIN-TAYBI SYNDROME	0.004594134000000001	0.4417765746966722
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004594134000000001	0.4417765746966722
JOUBERT SYNDROME 10	0.004594134000000001	0.4417765746966722
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004594134000000001	0.4417765746966722
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.004594134000000001	0.4417765746966722
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004594134000000001	0.4417765746966722
FLOATING-HARBOR SYNDROME	0.004594134000000001	0.4417765746966722
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.004594134000000001	0.4417765746966722
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.4417765746966722
MENKES DISEASE	0.004532968	0.4358947902367724
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004532968	0.4358947902367724
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.004532968	0.4358947902367724
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.004532968	0.4358947902367724
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.004532968	0.4358947902367724
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004532968	0.4358947902367724
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.004532968	0.4358947902367724
MENTAL RETARDATION, X-LINKED 1	0.004532968	0.4358947902367724
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.004532968	0.4358947902367724
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004532968	0.4358947902367724
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.004532968	0.4358947902367724
ZUNICH NEUROECTODERMAL SYNDROME	0.004532968	0.4358947902367724
ADENYLOSUCCINATE LYASE DEFICIENCY	0.004532968	0.4358947902367724
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.004532968	0.4358947902367724
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.004532968	0.4358947902367724
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.004532968	0.4358947902367724
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.004116984	0.3958933478215924
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004116984	0.3958933478215924
8Q12 MICRODUPLICATION SYNDROME	0.004116984	0.3958933478215924
ACROMELIC FRONTONASAL DYSPLASIA	0.004116984	0.3958933478215924
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.004116984	0.3958933478215924
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.004116984	0.3958933478215924
TRISOMY 9P	0.004116984	0.3958933478215924
19P13.13 MICRODELETION SYNDROME	0.004116984	0.3958933478215924
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004116984	0.3958933478215924
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.004116984	0.3958933478215924
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.004116984	0.3958933478215924
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.004116984	0.3958933478215924
TREACHER-COLLINS SYNDROME	0.004116984	0.3958933478215924
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004116984	0.3958933478215924
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004116984	0.3958933478215924
SWEENEY-COX SYNDROME; SWCOS	0.004116984	0.3958933478215924
611961 STEVENSON-CAREY SYNDROME	0.004116984	0.3958933478215924
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.004116984	0.3958933478215924
AYMÉ-GRIPP SYNDROME	0.004116984	0.3958933478215924
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.004116984	0.3958933478215924
ELSAHY-WATERS SYNDROME; ESWS	0.004116984	0.3958933478215924
14Q22Q23 MICRODELETION SYNDROME	0.004116984	0.3958933478215924
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.004116984	0.3958933478215924
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004116984	0.3958933478215924
20Q11.2 MICRODUPLICATION SYNDROME	0.004116984	0.3958933478215924
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.004116984	0.3958933478215924
CDAGS SYNDROME	0.004116984	0.3958933478215924
MUENKE SYNDROME	0.004116984	0.3958933478215924
BARDET-BIEDL SYNDROME 8; BBS8	0.004116984	0.3958933478215924
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.004116984	0.3958933478215924
MONOSOMY 9P	0.004116984	0.3958933478215924
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004116984	0.3958933478215924
DE BARSY SYNDROME	0.004116984	0.3958933478215924
EVEN-PLUS SYNDROME	0.004116984	0.3958933478215924
CREE MENTAL RETARDATION SYNDROME	0.004116984	0.3958933478215924
FETAL TRIMETHADIONE SYNDROME	0.004116984	0.3958933478215924
GERMAN SYNDROME	0.004116984	0.3958933478215924
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00404858	0.38931554995684775
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00404858	0.38931554995684775
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.38931554995684775
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.38931554995684775
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.38931554995684775
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00404858	0.38931554995684775
INCLUSION BODY MYOSITIS	0.00404858	0.38931554995684775
JEUNE SYNDROME	0.00404858	0.38931554995684775
ESOPHAGEAL ATRESIA	0.00404858	0.38931554995684775
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.38931554995684775
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.38931554995684775
MALAN OVERGROWTH SYNDROME	0.00404858	0.38931554995684775
STICKLER SYNDROME	0.00404858	0.38931554995684775
HYPOPHOSPHATASIA	0.00404858	0.38931554995684775
ACROCARDIOFACIAL SYNDROME	0.00404858	0.38931554995684775
HYPOADRENOCORTICISM, FAMILIAL	0.00404858	0.38931554995684775
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.38931554995684775
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.38931554995684775
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00404858	0.38931554995684775
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00404858	0.38931554995684775
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00404858	0.38931554995684775
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.38931554995684775
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.38931554995684775
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00404858	0.38931554995684775
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00404858	0.38931554995684775
RING CHROMOSOME 1 SYNDROME	0.00404858	0.38931554995684775
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.38931554995684775
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00404858	0.38931554995684775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.38931554995684775
PEMPHIGUS VULGARIS	0.00404858	0.38931554995684775
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00404858	0.38931554995684775
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00404858	0.38931554995684775
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00404858	0.38931554995684775
APERT SYNDROME	0.00404858	0.38931554995684775
COFFIN-LOWRY SYNDROME	0.00404858	0.38931554995684775
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.38931554995684775
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.38931554995684775
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00404858	0.38931554995684775
LEPRECHAUNISM	0.00404858	0.38931554995684775
SYSTEMIC SCLEROSIS	0.00404858	0.38931554995684775
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.38931554995684775
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.38931554995684775
MEIER-GORLIN SYNDROME 1; MGORS1	0.00404858	0.38931554995684775
FREEMAN-SHELDON SYNDROME	0.00404858	0.38931554995684775
CHERUBISM	0.00404858	0.38931554995684775
PIERRE ROBIN SYNDROME	0.00404858	0.38931554995684775
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00404858	0.38931554995684775
BOWEN-CONRADI SYNDROME	0.00404858	0.38931554995684775
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.38931554995684775
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.38931554995684775
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.38931554995684775
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.38931554995684775
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.38931554995684775
DERMATOMYOSITIS	0.00404858	0.38931554995684775
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.38931554995684775
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00357143	0.3434323230817681
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00357143	0.3434323230817681
BRANCHIOSKELETOGENITAL SYNDROME	0.00357143	0.3434323230817681
SHORT RIB-POLYDACTYLY SYNDROME	0.00357143	0.3434323230817681
GRANT SYNDROME	0.00357143	0.3434323230817681
RING CHROMOSOME 7 SYNDROME	0.00357143	0.3434323230817681
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00357143	0.3434323230817681
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00357143	0.3434323230817681
CROUZON DISEASE	0.00357143	0.3434323230817681
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00357143	0.3434323230817681
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00357143	0.3434323230817681
ACHARD SYNDROME	0.00357143	0.3434323230817681
DISTAL MONOSOMY 3P	0.00357143	0.3434323230817681
COOPER-JABS SYNDROME	0.00357143	0.3434323230817681
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00357143	0.3434323230817681
CEREBROFACIOTHORACIC DYSPLASIA	0.00357143	0.3434323230817681
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00357143	0.3434323230817681
CLEIDOCRANIAL DYSPLASIA	0.00357143	0.3434323230817681
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00357143	0.3434323230817681
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00357143	0.3434323230817681
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00357143	0.3434323230817681
DYSOSTOSIS, STANESCU TYPE	0.00357143	0.3434323230817681
FRONTOFACIONASAL DYSPLASIA	0.00357143	0.3434323230817681
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00357143	0.3434323230817681
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00357143	0.3434323230817681
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00357143	0.3434323230817681
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00357143	0.3434323230817681
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00357143	0.3434323230817681
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00357143	0.3434323230817681
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00357143	0.3434323230817681
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00357143	0.3434323230817681
NON-DISTAL TRISOMY 10Q	0.00357143	0.3434323230817681
CROUZON SYNDROME	0.00357143	0.3434323230817681
CRANIOFRONTONASAL DYSPLASIA	0.00357143	0.3434323230817681
HYPERTELORISM, TEEBI TYPE	0.00357143	0.3434323230817681
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00357143	0.3434323230817681
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00357143	0.3434323230817681
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00357143	0.3434323230817681
SMITH-FINEMAN-MYERS SYNDROME	0.00357143	0.3434323230817681
TRISOMY 20P	0.00357143	0.3434323230817681
WARBURG MICRO SYNDROME 2; WARBM2	0.00357143	0.3434323230817681
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00357143	0.3434323230817681
OSTEOGENESIS IMPERFECTA	0.00357143	0.3434323230817681
NEUROFACIODIGITORENAL SYNDROME	0.00357143	0.3434323230817681
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00357143	0.3434323230817681
CEREBROOCULONASAL SYNDROME	0.00357143	0.3434323230817681
WARBURG MICRO SYNDROME 3; WARBM3	0.00357143	0.3434323230817681
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00357143	0.3434323230817681
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00357143	0.3434323230817681
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00357143	0.3434323230817681
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00357143	0.3434323230817681
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00357143	0.3434323230817681
GORLIN SYNDROME	0.00357143	0.3434323230817681
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00357143	0.3434323230817681
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00357143	0.3434323230817681
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00357143	0.3434323230817681
9P13 MICRODELETION SYNDROME	0.00357143	0.3434323230817681
PFEIFFER SYNDROME TYPE 1	0.00357143	0.3434323230817681
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00357143	0.3434323230817681
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00357143	0.3434323230817681
RENPENNING SYNDROME 1; RENS1	0.00357143	0.3434323230817681
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00357143	0.3434323230817681
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00357143	0.3434323230817681
HAMAMY SYNDROME; HMMS	0.00357143	0.3434323230817681
ROBERTS SYNDROME; RBS	0.00357143	0.3434323230817681
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00357143	0.3434323230817681
PSEUDODIASTROPHIC DYSPLASIA	0.00357143	0.3434323230817681
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00357143	0.3434323230817681
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00357143	0.3434323230817681
CEREBROOCULONASAL SYNDROME	0.00357143	0.3434323230817681
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00357143	0.3434323230817681
HUNTER-MACDONALD SYNDROME	0.00357143	0.3434323230817681
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00357143	0.3434323230817681
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00357143	0.3434323230817681
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00357143	0.3434323230817681
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00357143	0.3434323230817681
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00357143	0.3434323230817681
LAURENCE-MOON SYNDROME	0.00357143	0.3434323230817681
SAETHRE-CHOTZEN SYNDROME	0.00357143	0.3434323230817681
AYME-GRIPP SYNDROME; AYGRP	0.00357143	0.3434323230817681
ISOLATED BRACHYCEPHALY	0.00357143	0.3434323230817681
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00357143	0.3434323230817681
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00357143	0.3434323230817681
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00357143	0.3434323230817681
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00357143	0.3434323230817681
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00357143	0.3434323230817681
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00357143	0.3434323230817681
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00357143	0.3434323230817681
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00357143	0.3434323230817681
2Q23.1 MICRODELETION SYNDROME	0.00357143	0.3434323230817681
MARSHALL SYNDROME	0.00357143	0.3434323230817681
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00357143	0.3434323230817681
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00357143	0.3434323230817681
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00357143	0.3434323230817681
ANTLEY-BIXLER SYNDROME	0.00357143	0.3434323230817681
AICA-RIBOSIDURIA	0.00357143	0.3434323230817681
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00357143	0.3434323230817681
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00357143	0.3434323230817681
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00357143	0.3434323230817681
POTOCKI-SHAFFER SYNDROME	0.00357143	0.3434323230817681
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00357143	0.3434323230817681
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.003210672	0.30874146871521674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003210672	0.30874146871521674
SIALIDOSIS TYPE 2	0.003210672	0.30874146871521674
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003210672	0.30874146871521674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.003210672	0.30874146871521674
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.003210672	0.30874146871521674
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.003210672	0.30874146871521674
NIEMANN-PICK DISEASE, TYPE C2	0.003210672	0.30874146871521674
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.003210672	0.30874146871521674
INFANTILE LIVER FAILURE SYNDROME 1	0.003210672	0.30874146871521674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003210672	0.30874146871521674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.003210672	0.30874146871521674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.003210672	0.30874146871521674
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.003210672	0.30874146871521674
PYRUVATE CARBOXYLASE DEFICIENCY	0.003210672	0.30874146871521674
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.003210672	0.30874146871521674
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003210672	0.30874146871521674
ARIMA SYNDROME	0.003210672	0.30874146871521674
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.003210672	0.30874146871521674
PEROXISOME BIOGENESIS DISORDER 3B	0.003210672	0.30874146871521674
GALACTOSE EPIMERASE DEFICIENCY	0.003210672	0.30874146871521674
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.003210672	0.30874146871521674
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.003210672	0.30874146871521674
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.003210672	0.30874146871521674
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.003210672	0.30874146871521674
COACH SYNDROME	0.003210672	0.30874146871521674
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.003210672	0.30874146871521674
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.003210672	0.30874146871521674
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003210672	0.30874146871521674
C SYNDROME	0.003210672	0.30874146871521674
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.003210672	0.30874146871521674
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.003210672	0.30874146871521674
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.003210672	0.30874146871521674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.003210672	0.30874146871521674
GLYCOGEN STORAGE DISEASE IXB	0.002665118	0.2562804439753924
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.002665118	0.2562804439753924
GLYCOGEN STORAGE DISEASE IXC	0.002665118	0.2562804439753924
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002665118	0.2562804439753924
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002665118	0.2562804439753924
ZIMMERMANN-LABAND SYNDROME 1	0.002665118	0.2562804439753924
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002665118	0.2562804439753924
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.002665118	0.2562804439753924
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.002665118	0.2562804439753924
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.002665118	0.2562804439753924
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.002665118	0.2562804439753924
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002665118	0.2562804439753924
NEURAMINIDASE DEFICIENCY	0.002665118	0.2562804439753924
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.002665118	0.2562804439753924
PSEUDO-TORCH SYNDROME 2	0.002665118	0.2562804439753924
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002665118	0.2562804439753924
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002665118	0.2562804439753924
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.002665118	0.2562804439753924
GLYCOGEN STORAGE DISEASE II	0.002665118	0.2562804439753924
GLUTARIC ACIDEMIA I; GA1	0.002665118	0.2562804439753924
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.002665118	0.2562804439753924
COMBINED SAPOSIN DEFICIENCY	0.002665118	0.2562804439753924
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.002665118	0.2562804439753924
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.002665118	0.2562804439753924
NEUTRAL LIPID STORAGE MYOPATHY	0.002665118	0.2562804439753924
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002665118	0.2562804439753924
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002665118	0.2562804439753924
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.002665118	0.2562804439753924
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002249134	0.21627900156021237
DYSKERATOSIS CONGENITA	0.002249134	0.21627900156021237
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.002249134	0.21627900156021237
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002249134	0.21627900156021237
LATHOSTEROLOSIS	0.002249134	0.21627900156021237
TAY-SACHS DISEASE	0.002249134	0.21627900156021237
SIMPSON-GOLABI-BEHMEL SYNDROME	0.002249134	0.21627900156021237
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002249134	0.21627900156021237
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.002249134	0.21627900156021237
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002249134	0.21627900156021237
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.002249134	0.21627900156021237
TRANSKETOLASE DEFICIENCY	0.002249134	0.21627900156021237
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.002249134	0.21627900156021237
NIEMANN-PICK DISEASE TYPE C	0.002249134	0.21627900156021237
PYRIDOXINE-DEPENDENT EPILEPSY	0.002249134	0.21627900156021237
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.002249134	0.21627900156021237
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.002249134	0.21627900156021237
HURLER SYNDROME	0.002249134	0.21627900156021237
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.002249134	0.21627900156021237
GALACTOSE EPIMERASE DEFICIENCY	0.002249134	0.21627900156021237
HURLER SYNDROME	0.002249134	0.21627900156021237
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002249134	0.21627900156021237
PERLMAN SYNDROME	0.002249134	0.21627900156021237
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.002249134	0.21627900156021237
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.002249134	0.21627900156021237
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.002249134	0.21627900156021237
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.002249134	0.21627900156021237
ISOLATED COMPLEX I DEFICIENCY	0.002249134	0.21627900156021237
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.002249134	0.21627900156021237
CITRULLINEMIA, CLASSIC	0.002249134	0.21627900156021237
RFT1-CDG	0.002249134	0.21627900156021237
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002249134	0.21627900156021237
WOLMAN DISEASE	0.002249134	0.21627900156021237
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002249134	0.21627900156021237
ALPHA-MANNOSIDOSIS	0.002249134	0.21627900156021237
FREE SIALIC ACID STORAGE DISEASE	0.002249134	0.21627900156021237
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.002249134	0.21627900156021237
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.002249134	0.21627900156021237
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.002249134	0.21627900156021237
MULTIPLE SULFATASE DEFICIENCY	0.002249134	0.21627900156021237
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002249134	0.21627900156021237
MUCOPOLYSACCHARIDOSIS TYPE 2	0.002249134	0.21627900156021237
FARBER DISEASE	0.002249134	0.21627900156021237
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.002249134	0.21627900156021237
SANDHOFF DISEASE	0.00170358	0.16381797682038804
REYNOLDS SYNDROME	0.00170358	0.16381797682038804
AMISH LETHAL MICROCEPHALY	0.00170358	0.16381797682038804
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.16381797682038804
HEREDITARY SPHEROCYTOSIS	0.00170358	0.16381797682038804
LEPTOSPIROSIS	0.00170358	0.16381797682038804
POLYCYTHEMIA VERA	0.00170358	0.16381797682038804
MAJEED SYNDROME	0.00170358	0.16381797682038804
GAUCHER DISEASE TYPE 2	0.00170358	0.16381797682038804
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.16381797682038804
PRIMARY MYELOFIBROSIS	0.00170358	0.16381797682038804
ADULT-ONSET STILL DISEASE	0.00170358	0.16381797682038804
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00170358	0.16381797682038804
POLYMYOSITIS	0.00170358	0.16381797682038804
PROLIDASE DEFICIENCY	0.00170358	0.16381797682038804
MAST CELL SARCOMA	0.00170358	0.16381797682038804
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00170358	0.16381797682038804
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00170358	0.16381797682038804
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00170358	0.16381797682038804
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.00170358	0.16381797682038804
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.00170358	0.16381797682038804
PLEURAL MESOTHELIOMA	0.00170358	0.16381797682038804
CYSTIC FIBROSIS	0.00170358	0.16381797682038804
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00170358	0.16381797682038804
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00170358	0.16381797682038804
MUCOLIPIDOSIS TYPE II	0.00170358	0.16381797682038804
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00170358	0.16381797682038804
HB BART'S HYDROPS FETALIS	0.00170358	0.16381797682038804
COLD AGGLUTININ DISEASE	0.00170358	0.16381797682038804
LCAT DEFICIENCY	0.00170358	0.16381797682038804
TYPHOID	0.00170358	0.16381797682038804
FISH-EYE DISEASE	0.00170358	0.16381797682038804
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00170358	0.16381797682038804
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00170358	0.16381797682038804
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.16381797682038804
EISENMENGER SYNDROME	0.00170358	0.16381797682038804
HEREDITARY FRUCTOSE INTOLERANCE	0.00170358	0.16381797682038804
SCHEIE SYNDROME	0.00170358	0.16381797682038804
CLASSIC MYCOSIS FUNGOIDES	0.00170358	0.16381797682038804
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.16381797682038804
OPSISMODYSPLASIA	0.00170358	0.16381797682038804
ACROCEPHALOSYNDACTYLY	0.00170358	0.16381797682038804
PACHYDERMOPERIOSTOSIS	0.00170358	0.16381797682038804
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00170358	0.16381797682038804
HURLER-SCHEIE SYNDROME	0.00170358	0.16381797682038804
HODGKIN LYMPHOMA	0.00170358	0.16381797682038804
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00170358	0.16381797682038804
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00170358	0.16381797682038804
CONGENITAL RUBELLA SYNDROME	0.00170358	0.16381797682038804
CRONKHITE-CANADA SYNDROME	0.00170358	0.16381797682038804
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.16381797682038804
ASPARTYLGLUCOSAMINURIA	0.00170358	0.16381797682038804
JUVENILE IDIOPATHIC ARTHRITIS	0.00170358	0.16381797682038804
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00170358	0.16381797682038804
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00170358	0.16381797682038804
CRYOGLOBULINEMIC VASCULITIS	0.00170358	0.16381797682038804
MULIBREY NANISM	0.00170358	0.16381797682038804
SOMATOSTATINOMA	0.00170358	0.16381797682038804
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.16381797682038804
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00170358	0.16381797682038804
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00170358	0.16381797682038804
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00170358	0.16381797682038804
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.00170358	0.16381797682038804
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00170358	0.16381797682038804
PACHYONYCHIA CONGENITA	0.00170358	0.16381797682038804
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00170358	0.16381797682038804
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.16381797682038804
DUBIN-JOHNSON SYNDROME	0.00170358	0.16381797682038804
GRFOMA	0.00170358	0.16381797682038804
VIPOMA	0.00170358	0.16381797682038804
PPOMA	0.00170358	0.16381797682038804
CHOREOACANTHOCYTOSIS	0.00170358	0.16381797682038804
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.16381797682038804
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00170358	0.16381797682038804
GLUCAGONOMA	0.00170358	0.16381797682038804
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.16381797682038804
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.16381797682038804
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00170358	0.16381797682038804
SÉZARY SYNDROME	0.00170358	0.16381797682038804
DK1-CDG	0.00170358	0.16381797682038804
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00170358	0.16381797682038804
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.16381797682038804
SCHNITZLER SYNDROME	0.00170358	0.16381797682038804
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.16381797682038804
CHRONIC GRANULOMATOUS DISEASE	0.00170358	0.16381797682038804
CLASSIC HODGKIN LYMPHOMA	0.00170358	0.16381797682038804
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00170358	0.16381797682038804
CLASSIC HOMOCYSTINURIA	0.00170358	0.16381797682038804
AL AMYLOIDOSIS	0.00170358	0.16381797682038804
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00170358	0.16381797682038804
PRIMARY SCLEROSING CHOLANGITIS	0.00170358	0.16381797682038804
WILSON DISEASE	0.00170358	0.16381797682038804
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00170358	0.16381797682038804
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.00170358	0.16381797682038804
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00170358	0.16381797682038804
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00170358	0.16381797682038804
FETAL GAUCHER DISEASE	0.00170358	0.16381797682038804
BETA-THALASSEMIA	0.00170358	0.16381797682038804
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.16381797682038804
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00170358	0.16381797682038804
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00170358	0.16381797682038804
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00170358	0.16381797682038804
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00170358	0.16381797682038804
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00170358	0.16381797682038804
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00170358	0.16381797682038804
KLIPPEL-TRÉNAUNAY SYNDROME	0.00170358	0.16381797682038804
WILD TYPE ATTR AMYLOIDOSIS	0.00170358	0.16381797682038804
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.00170358	0.16381797682038804
WALDENSTRÖM MACROGLOBULINEMIA	0.00170358	0.16381797682038804
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00170358	0.16381797682038804
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00170358	0.16381797682038804
TRIPLOIDY	0.00170358	0.16381797682038804
AMERICAN TRYPANOSOMIASIS	0.00170358	0.16381797682038804
HEPATIC VENO-OCCLUSIVE DISEASE	0.00170358	0.16381797682038804
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00170358	0.16381797682038804
HEPATOCELLULAR CARCINOMA	0.00170358	0.16381797682038804
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.16381797682038804
TYROSINEMIA TYPE 1	0.00170358	0.16381797682038804
PULMONARY ARTERIAL HYPERTENSION	0.00170358	0.16381797682038804
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00170358	0.16381797682038804
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.16381797682038804
SEA-BLUE HISTIOCYTOSIS	0.00170358	0.16381797682038804
KLATSKIN TUMOR	0.00170358	0.16381797682038804
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00170358	0.16381797682038804
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00170358	0.16381797682038804
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00170358	0.16381797682038804
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.16381797682038804
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.00170358	0.16381797682038804
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00170358	0.16381797682038804
SCLEROSING CHOLANGITIS, NEONATAL	0.00170358	0.16381797682038804
CAROLI DISEASE, ISOLATED	0.00170358	0.16381797682038804
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00170358	0.16381797682038804
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.16381797682038804
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00170358	0.16381797682038804
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.16381797682038804
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00170358	0.16381797682038804
HEMOCHROMATOSIS, TYPE 2A	0.00170358	0.16381797682038804
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.16381797682038804
SICKLE CELL ANEMIA	0.00170358	0.16381797682038804
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.16381797682038804
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00170358	0.16381797682038804
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.16381797682038804
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00170358	0.16381797682038804
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00170358	0.16381797682038804
MORQUIO SYNDROME A	0.00170358	0.16381797682038804
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00170358	0.16381797682038804
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00170358	0.16381797682038804
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00170358	0.16381797682038804
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00170358	0.16381797682038804
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00170358	0.16381797682038804
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00170358	0.16381797682038804
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00170358	0.16381797682038804
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00170358	0.16381797682038804
CHANARIN-DORFMAN SYNDROME	0.00170358	0.16381797682038804
TYROSINEMIA, TYPE I; TYRSN1	0.00170358	0.16381797682038804
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.16381797682038804
NEPHRONOPHTHISIS 19; NPHP19	0.00170358	0.16381797682038804
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00170358	0.16381797682038804
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00170358	0.16381797682038804
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.00170358	0.16381797682038804
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.00170358	0.16381797682038804
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00170358	0.16381797682038804
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00170358	0.16381797682038804
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00170358	0.16381797682038804
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00170358	0.16381797682038804
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.16381797682038804
HARDIKAR SYNDROME	0.00170358	0.16381797682038804
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00170358	0.16381797682038804
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.16381797682038804
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00170358	0.16381797682038804
HEMOCHROMATOSIS, TYPE 2B	0.00170358	0.16381797682038804
REYNOLDS SYNDROME	0.00170358	0.16381797682038804
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00170358	0.16381797682038804
TRICHOHEPATOENTERIC SYNDROME 2	0.00170358	0.16381797682038804
RETINITIS PIGMENTOSA 59; RP59	0.00170358	0.16381797682038804
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.00170358	0.16381797682038804
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00170358	0.16381797682038804
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00170358	0.16381797682038804
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00170358	0.16381797682038804
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.16381797682038804
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00170358	0.16381797682038804
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00170358	0.16381797682038804
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.16381797682038804
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00170358	0.16381797682038804
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00170358	0.16381797682038804
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.16381797682038804
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.00170358	0.16381797682038804
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.16381797682038804
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00170358	0.16381797682038804
HURLER-SCHEIE SYNDROME	0.00170358	0.16381797682038804
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00170358	0.16381797682038804
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.16381797682038804
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00170358	0.16381797682038804
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.16381797682038804
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00170358	0.16381797682038804
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00170358	0.16381797682038804
AFRICAN IRON OVERLOAD	0.00170358	0.16381797682038804
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00170358	0.16381797682038804
PORTAL HYPERTENSION, NONCIRRHOTIC	0.00170358	0.16381797682038804
GAUCHER DISEASE, TYPE IIIC	0.00170358	0.16381797682038804
BUDD-CHIARI SYNDROME	0.00170358	0.16381797682038804
GAUCHER DISEASE, TYPE I	0.00170358	0.16381797682038804
MU-HEAVY CHAIN DISEASE	0.00170358	0.16381797682038804
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.16381797682038804
GALACTOSEMIA	0.00170358	0.16381797682038804
GAMMA-HEAVY CHAIN DISEASE	0.00170358	0.16381797682038804
NEUROENDOCRINE TUMOR OF STOMACH	0.00170358	0.16381797682038804
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.16381797682038804
NEUROENDOCRINE TUMOR OF THE COLON	0.00170358	0.16381797682038804
HISTIOCYTOID CARDIOMYOPATHY	0.00170358	0.16381797682038804
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00170358	0.16381797682038804
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00170358	0.16381797682038804
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00170358	0.16381797682038804
CRANIOECTODERMAL DYSPLASIA 1	0.00170358	0.16381797682038804
BETA-KETOTHIOLASE DEFICIENCY	0.00170358	0.16381797682038804
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00170358	0.16381797682038804
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00170358	0.16381797682038804
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.00170358	0.16381797682038804
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00170358	0.16381797682038804
CAMPOMELIA, CUMMING TYPE	0.00170358	0.16381797682038804
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00170358	0.16381797682038804
AREDYLD SYNDROME	0.00170358	0.16381797682038804
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.16381797682038804
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.16381797682038804
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00170358	0.16381797682038804
POLYCYSTIC LIVER DISEASE 2	0.00170358	0.16381797682038804
BECKWITH-WIEDEMANN SYNDROME	0.00170358	0.16381797682038804
TANGIER DISEASE; TGD	0.00170358	0.16381797682038804
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00170358	0.16381797682038804
HEMOCHROMATOSIS, TYPE 1	0.00170358	0.16381797682038804
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00170358	0.16381797682038804
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00170358	0.16381797682038804
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00170358	0.16381797682038804
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00170358	0.16381797682038804
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00170358	0.16381797682038804
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00170358	0.16381797682038804
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00170358	0.16381797682038804
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.16381797682038804
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00170358	0.16381797682038804
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00170358	0.16381797682038804
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00170358	0.16381797682038804
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001507092	0.1449234918948287
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001507092	0.1449234918948287
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.001507092	0.1449234918948287
JOUBERT SYNDROME 14	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001507092	0.1449234918948287
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001507092	0.1449234918948287
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001507092	0.1449234918948287
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001507092	0.1449234918948287
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001507092	0.1449234918948287
JOUBERT SYNDROME 15	0.001507092	0.1449234918948287
COFFIN-SIRIS SYNDROME 3; CSS3	0.001507092	0.1449234918948287
MEND SYNDROME	0.001507092	0.1449234918948287
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001507092	0.1449234918948287
PEROXISOME BIOGENESIS DISORDER 5B	0.001507092	0.1449234918948287
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001507092	0.1449234918948287
COFFIN-SIRIS SYNDROME 4; CSS4	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001507092	0.1449234918948287
PEROXISOME BIOGENESIS DISORDER 6B	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001507092	0.1449234918948287
SALT-AND-PEPPER SYNDROME	0.001507092	0.1449234918948287
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.1449234918948287
SSR4-CDG	0.001507092	0.1449234918948287
STT3B-CDG	0.001507092	0.1449234918948287
STT3A-CDG	0.001507092	0.1449234918948287
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.1449234918948287
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001507092	0.1449234918948287
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001507092	0.1449234918948287
PONTINE TEGMENTAL CAP DYSPLASIA	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001507092	0.1449234918948287
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001507092	0.1449234918948287
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001507092	0.1449234918948287
JOUBERT SYNDROME 24	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.001507092	0.1449234918948287
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001507092	0.1449234918948287
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001507092	0.1449234918948287
JOUBERT SYNDROME 25	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.001507092	0.1449234918948287
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001507092	0.1449234918948287
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.1449234918948287
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001507092	0.1449234918948287
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001507092	0.1449234918948287
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001507092	0.1449234918948287
AL-RAQAD SYNDROME; ARS	0.001507092	0.1449234918948287
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001507092	0.1449234918948287
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.1449234918948287
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.1449234918948287
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001507092	0.1449234918948287
AU-KLINE SYNDROME; AUKS	0.001507092	0.1449234918948287
RING CHROMOSOME 14 SYNDROME	0.001507092	0.1449234918948287
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.1449234918948287
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001507092	0.1449234918948287
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001507092	0.1449234918948287
TARP SYNDROME	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001507092	0.1449234918948287
CHROMOSOME 5Q12 DELETION SYNDROME	0.001507092	0.1449234918948287
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001507092	0.1449234918948287
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001507092	0.1449234918948287
YOU-HOOVER-FONG SYNDROME; YHFS	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001507092	0.1449234918948287
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001507092	0.1449234918948287
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001507092	0.1449234918948287
JOUBERT SYNDROME 21	0.001507092	0.1449234918948287
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001507092	0.1449234918948287
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001507092	0.1449234918948287
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.001507092	0.1449234918948287
LAMB-SHAFFER SYNDROME	0.001507092	0.1449234918948287
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001507092	0.1449234918948287
XIA-GIBBS SYNDROME	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001507092	0.1449234918948287
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001507092	0.1449234918948287
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001507092	0.1449234918948287
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001507092	0.1449234918948287
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001507092	0.1449234918948287
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001507092	0.1449234918948287
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.001507092	0.1449234918948287
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001507092	0.1449234918948287
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.1449234918948287
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.001507092	0.1449234918948287
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001507092	0.1449234918948287
SULFOCYSTEINURIA	0.001507092	0.1449234918948287
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001507092	0.1449234918948287
OROFACIODIGITAL SYNDROME VI	0.001507092	0.1449234918948287
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001507092	0.1449234918948287
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001507092	0.1449234918948287
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001507092	0.1449234918948287
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001507092	0.1449234918948287
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001507092	0.1449234918948287
MENTAL RETARDATION, X-LINKED 41	0.001507092	0.1449234918948287
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001507092	0.1449234918948287
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001507092	0.1449234918948287
MEND SYNDROME; MEND	0.001507092	0.1449234918948287
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.001507092	0.1449234918948287
XQ25 DUPLICATION SYNDROME	0.001507092	0.1449234918948287
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001507092	0.1449234918948287
PETTIGREW SYNDROME	0.001507092	0.1449234918948287
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.001507092	0.1449234918948287
ELEJALDE DISEASE	0.001507092	0.1449234918948287
LEIGH SYNDROME; LS	0.001507092	0.1449234918948287
PELIZAEUS-MERZBACHER DISEASE	0.001507092	0.1449234918948287
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.1449234918948287
ADAMS-OLIVER SYNDROME 1; AOS1	0.001507092	0.1449234918948287
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.001507092	0.1449234918948287
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.001507092	0.1449234918948287
HOLOPROSENCEPHALY 2; HPE2	0.001507092	0.1449234918948287
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA TYPE 13	0.001507092	0.1449234918948287
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.1449234918948287
MICROPHTHALMIA, SYNDROMIC 3	0.001507092	0.1449234918948287
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001507092	0.1449234918948287
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.001507092	0.1449234918948287
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001507092	0.1449234918948287
JOUBERT SYNDROME 1	0.001507092	0.1449234918948287
GRISCELLI SYNDROME, TYPE 1	0.001507092	0.1449234918948287
TEMTAMY SYNDROME; TEMTYS	0.001507092	0.1449234918948287
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001507092	0.1449234918948287
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001507092	0.1449234918948287
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001507092	0.1449234918948287
CEREBELLAR ATAXIA, CAYMAN TYPE	0.001507092	0.1449234918948287
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001507092	0.1449234918948287
HOLOPROSENCEPHALY 1; HPE1	0.001507092	0.1449234918948287
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001507092	0.1449234918948287
VICI SYNDROME; VICIS	0.001507092	0.1449234918948287
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001507092	0.1449234918948287
KETOADIPICACIDURIA	0.001507092	0.1449234918948287
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001507092	0.1449234918948287
MARINESCO-SJOGREN SYNDROME; MSS	0.001507092	0.1449234918948287
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001507092	0.1449234918948287
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001507092	0.1449234918948287
MUCOLIPIDOSIS IV; ML4	0.001507092	0.1449234918948287
TARP SYNDROME; TARPS	0.001507092	0.1449234918948287
WIEACKER-WOLFF SYNDROME	0.001507092	0.1449234918948287
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001507092	0.1449234918948287
WARSAW BREAKAGE SYNDROME; WABS	0.001507092	0.1449234918948287
8Q24.3 MICRODELETION SYNDROME	0.001507092	0.1449234918948287
JOUBERT SYNDROME 6	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001507092	0.1449234918948287
JOUBERT SYNDROME 7	0.001507092	0.1449234918948287
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001507092	0.1449234918948287
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001507092	0.1449234918948287
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001507092	0.1449234918948287
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.001507092	0.1449234918948287
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001507092	0.1449234918948287
JOUBERT SYNDROME 8	0.001507092	0.1449234918948287
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001507092	0.1449234918948287
HADZISELIMOVIC SYNDROME	0.001507092	0.1449234918948287
NOONAN SYNDROME 6; NS6	0.001507092	0.1449234918948287
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001507092	0.1449234918948287
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001507092	0.1449234918948287
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.1449234918948287
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001507092	0.1449234918948287
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001507092	0.1449234918948287
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001507092	0.1449234918948287
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001507092	0.1449234918948287
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.1449234918948287
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001507092	0.1449234918948287
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001507092	0.1449234918948287
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.1449234918948287
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001507092	0.1449234918948287
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001507092	0.1449234918948287
MEVALONIC ACIDURIA; MEVA	0.001507092	0.1449234918948287
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001507092	0.1449234918948287
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001507092	0.1449234918948287
CODAS SYNDROME	0.001507092	0.1449234918948287
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.1449234918948287
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001507092	0.1449234918948287
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001507092	0.1449234918948287
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001507092	0.1449234918948287
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001507092	0.1449234918948287
SALLA DISEASE	0.001507092	0.1449234918948287
BOHRING-OPITZ SYNDROME	0.001507092	0.1449234918948287
GENITOPATELLAR SYNDROME; GTPTS	0.001507092	0.1449234918948287
FUMARASE DEFICIENCY; FMRD	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.1449234918948287
DIAPHANOSPONDYLODYSOSTOSIS	0.001507092	0.1449234918948287
JOUBERT SYNDROME 2	0.001507092	0.1449234918948287
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001507092	0.1449234918948287
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.001507092	0.1449234918948287
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.001507092	0.1449234918948287
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001507092	0.1449234918948287
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.1449234918948287
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.1449234918948287
EMANUEL SYNDROME	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001507092	0.1449234918948287
SCHINDLER DISEASE, TYPE I	0.001507092	0.1449234918948287
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001507092	0.1449234918948287
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001507092	0.1449234918948287
GOLDBERG-SHPRINTZEN SYNDROME	0.001507092	0.1449234918948287
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001507092	0.1449234918948287
CHROMOSOME 10Q26 DELETION SYNDROME	0.001507092	0.1449234918948287
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001507092	0.1449234918948287
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001507092	0.1449234918948287
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.001507092	0.1449234918948287
PEROXISOME BIOGENESIS DISORDER 10B	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001507092	0.1449234918948287
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001507092	0.1449234918948287
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001507092	0.1449234918948287
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001507092	0.1449234918948287
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001507092	0.1449234918948287
NOONAN SYNDROME 11; NS11	0.001507092	0.1449234918948287
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001507092	0.1449234918948287
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001507092	0.1449234918948287
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA TYPE 29	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001507092	0.1449234918948287
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001507092	0.1449234918948287
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001507092	0.1449234918948287
IMMUNODEFICIENCY 49; IMD49	0.001507092	0.1449234918948287
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001507092	0.1449234918948287
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001507092	0.1449234918948287
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001507092	0.1449234918948287
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001507092	0.1449234918948287
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001507092	0.1449234918948287
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.001507092	0.1449234918948287
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001507092	0.1449234918948287
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001507092	0.1449234918948287
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001507092	0.1449234918948287
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001507092	0.1449234918948287
OPTIC ATROPHY 11; OPA11	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001507092	0.1449234918948287
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001507092	0.1449234918948287
HAREL-YOON SYNDROME; HAYOS	0.001507092	0.1449234918948287
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.1449234918948287
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.1449234918948287
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001507092	0.1449234918948287
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001507092	0.1449234918948287
OROFACIODIGITAL SYNDROME XVI; OFD16	0.001507092	0.1449234918948287
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.001507092	0.1449234918948287
AURICULOCONDYLAR SYNDROME	0.001507092	0.1449234918948287
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001507092	0.1449234918948287
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001507092	0.1449234918948287
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001507092	0.1449234918948287
JOUBERT SYNDROME 35; JBTS35	0.001507092	0.1449234918948287
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001507092	0.1449234918948287
JOUBERT SYNDROME 28	0.001507092	0.1449234918948287
JOUBERT SYNDROME 27	0.001507092	0.1449234918948287
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001507092	0.1449234918948287
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001507092	0.1449234918948287
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001507092	0.1449234918948287
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001507092	0.1449234918948287
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001507092	0.1449234918948287
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001507092	0.1449234918948287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001507092	0.1449234918948287
COFFIN-SIRIS SYNDROME 7; CSS7	0.001507092	0.1449234918948287
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001507092	0.1449234918948287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.001507092	0.1449234918948287
COHEN-GIBSON SYNDROME; COGIS	0.001507092	0.1449234918948287
JOUBERT SYNDROME 31; JBTS31	0.001507092	0.1449234918948287
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001507092	0.1449234918948287
JOUBERT SYNDROME 32; JBTS32	0.001507092	0.1449234918948287
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.001507092	0.1449234918948287
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001507092	0.1449234918948287
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001507092	0.1449234918948287
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001507092	0.1449234918948287
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.09246246715500434
VERVERI-BRADY SYNDROME; VERBRAS	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0009615380000000001	0.09246246715500434
GLUTAMINE DEFICIENCY, CONGENITAL	0.0009615380000000001	0.09246246715500434
PIERSON SYNDROME	0.0009615380000000001	0.09246246715500434
JOUBERT SYNDROME 4	0.0009615380000000001	0.09246246715500434
PITT-HOPKINS SYNDROME	0.0009615380000000001	0.09246246715500434
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	0.09246246715500434
JOUBERT SYNDROME 3; JBTS3	0.0009615380000000001	0.09246246715500434
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0009615380000000001	0.09246246715500434
LEGIUS SYNDROME	0.0009615380000000001	0.09246246715500434
JOUBERT SYNDROME 5	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.09246246715500434
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0009615380000000001	0.09246246715500434
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.09246246715500434
ETHYLMALONIC ENCEPHALOPATHY	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.09246246715500434
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.09246246715500434
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.09246246715500434
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.09246246715500434
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
TEMPLE-BARAITSER SYNDROME	0.0009615380000000001	0.09246246715500434
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0009615380000000001	0.09246246715500434
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0009615380000000001	0.09246246715500434
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.09246246715500434
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0009615380000000001	0.09246246715500434
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0009615380000000001	0.09246246715500434
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.09246246715500434
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0009615380000000001	0.09246246715500434
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0009615380000000001	0.09246246715500434
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.09246246715500434
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.09246246715500434
SOTOS SYNDROME 2	0.0009615380000000001	0.09246246715500434
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.09246246715500434
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.09246246715500434
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.09246246715500434
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.09246246715500434
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.09246246715500434
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0009615380000000001	0.09246246715500434
LISSENCEPHALY 3; LIS3	0.0009615380000000001	0.09246246715500434
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.09246246715500434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0009615380000000001	0.09246246715500434
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	0.09246246715500434
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.09246246715500434
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.09246246715500434
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	0.09246246715500434
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	0.09246246715500434
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.09246246715500434
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.09246246715500434
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.09246246715500434
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	0.09246246715500434
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0009615380000000001	0.09246246715500434
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0009615380000000001	0.09246246715500434
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.09246246715500434
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.09246246715500434
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	0.09246246715500434
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0009615380000000001	0.09246246715500434
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.09246246715500434
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.09246246715500434
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.09246246715500434
LATHOSTEROLOSIS	0.0009615380000000001	0.09246246715500434
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0009615380000000001	0.09246246715500434
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	0.09246246715500434
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.09246246715500434
SENGERS SYNDROME	0.0009615380000000001	0.09246246715500434
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.09246246715500434
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.09246246715500434
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0009615380000000001	0.09246246715500434
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0009615380000000001	0.09246246715500434
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	0.09246246715500434
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	0.09246246715500434
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0009615380000000001	0.09246246715500434
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	0.09246246715500434
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.09246246715500434
ETHANOLAMINOSIS	0.0009615380000000001	0.09246246715500434
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.09246246715500434
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	0.09246246715500434
CAP MYOPATHY	0.0009615380000000001	0.09246246715500434
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.09246246715500434
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	0.09246246715500434
MOWAT-WILSON SYNDROME; MOWS	0.0009615380000000001	0.09246246715500434
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.09246246715500434
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0009615380000000001	0.09246246715500434
HYPOPHOSPHATASIA, INFANTILE	0.0009615380000000001	0.09246246715500434
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0009615380000000001	0.09246246715500434
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.09246246715500434
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	0.09246246715500434
MARDEN-WALKER SYNDROME	0.0009615380000000001	0.09246246715500434
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.09246246715500434
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.09246246715500434
ARTERIAL TORTUOSITY SYNDROME	0.0009615380000000001	0.09246246715500434
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.09246246715500434
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.09246246715500434
HUNTINGTON DISEASE-LIKE 1	0.0009615380000000001	0.09246246715500434
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.09246246715500434
CAMPOMELIC DYSPLASIA	0.0009615380000000001	0.09246246715500434
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.09246246715500434
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.09246246715500434
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.09246246715500434
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.09246246715500434
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.09246246715500434
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.09246246715500434
JACOBSEN SYNDROME	0.0009615380000000001	0.09246246715500434
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	0.09246246715500434
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.09246246715500434
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.09246246715500434
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	0.09246246715500434
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.09246246715500434
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.09246246715500434
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
ADDUCTED THUMBS SYNDROME	0.0009615380000000001	0.09246246715500434
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.09246246715500434
METACHROMATIC LEUKODYSTROPHY	0.0009615380000000001	0.09246246715500434
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.09246246715500434
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0009615380000000001	0.09246246715500434
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.09246246715500434
COFFIN-LOWRY SYNDROME; CLS	0.0009615380000000001	0.09246246715500434
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.09246246715500434
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.09246246715500434
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.09246246715500434
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.09246246715500434
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	0.09246246715500434
STUVE-WIEDEMANN SYNDROME	0.0009615380000000001	0.09246246715500434
PALLISTER-KILLIAN SYNDROME	0.0009615380000000001	0.09246246715500434
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.09246246715500434
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.09246246715500434
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.09246246715500434
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.09246246715500434
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	0.09246246715500434
GLYCINE ENCEPHALOPATHY; GCE	0.0009615380000000001	0.09246246715500434
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.09246246715500434
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.09246246715500434
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0009615380000000001	0.09246246715500434
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.09246246715500434
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.09246246715500434
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.0009615380000000001	0.09246246715500434
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.09246246715500434
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.09246246715500434
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.09246246715500434
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0009615380000000001	0.09246246715500434
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.09246246715500434
COFFIN-SIRIS SYNDROME 8; CSS8	0.0009615380000000001	0.09246246715500434
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.09246246715500434
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0009615380000000001	0.09246246715500434
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.09246246715500434
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.09246246715500434
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0009615380000000001	0.09246246715500434
XYLOSIDASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
LESCH-NYHAN SYNDROME; LNS	0.0009615380000000001	0.09246246715500434
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0009615380000000001	0.09246246715500434
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, X-LINKED 93	0.0009615380000000001	0.09246246715500434
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.09246246715500434
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	0.09246246715500434
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	0.09246246715500434
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.09246246715500434
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.09246246715500434
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.09246246715500434
DDOST-CDG	0.0009615380000000001	0.09246246715500434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	0.09246246715500434
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	0.09246246715500434
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.09246246715500434
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.09246246715500434
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.09246246715500434
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0009615380000000001	0.09246246715500434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.09246246715500434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.09246246715500434
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.09246246715500434
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0009615380000000001	0.09246246715500434
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.09246246715500434
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0009615380000000001	0.09246246715500434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.09246246715500434
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.09246246715500434
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0009615380000000001	0.09246246715500434
CHITAYAT SYNDROME	0.0009615380000000001	0.09246246715500434
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.09246246715500434
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0009615380000000001	0.09246246715500434
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.09246246715500434
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0009615380000000001	0.09246246715500434
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0009615380000000001	0.09246246715500434
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.09246246715500434
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.09246246715500434
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.09246246715500434
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.09246246715500434
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	0.09246246715500434
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.09246246715500434
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	0.09246246715500434
SIFRIM-HITZ-WEISS SYNDROME	0.0009615380000000001	0.09246246715500434
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.09246246715500434
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.09246246715500434
TRISOMY 8P	0.0009615380000000001	0.09246246715500434
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0009615380000000001	0.09246246715500434
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	0.09246246715500434
COG1-CDG	0.0009615380000000001	0.09246246715500434
LISSENCEPHALY 5; LIS5	0.0009615380000000001	0.09246246715500434
SMITH-KINGSMORE SYNDROME; SKS	0.0009615380000000001	0.09246246715500434
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0009615380000000001	0.09246246715500434
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0009615380000000001	0.09246246715500434
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0009615380000000001	0.09246246715500434
SYDENHAM CHOREA	0.0009615380000000001	0.09246246715500434
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	0.09246246715500434
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.09246246715500434
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.09246246715500434
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.09246246715500434
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.09246246715500434
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	0.09246246715500434
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.09246246715500434
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.09246246715500434
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	0.09246246715500434
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.09246246715500434
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.05246102473982435
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.05246102473982435
OROTIC ACIDURIA	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.05246102473982435
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.05246102473982435
GENITOPATELLAR SYNDROME	0.000545554	0.05246102473982435
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.05246102473982435
WAARDENBURG-SHAH SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.05246102473982435
CONGENITAL VARICELLA SYNDROME	0.000545554	0.05246102473982435
KEUTEL SYNDROME	0.000545554	0.05246102473982435
NOONAN SYNDROME 9; NS9	0.000545554	0.05246102473982435
LISSENCEPHALY 8; LIS8	0.000545554	0.05246102473982435
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.05246102473982435
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.05246102473982435
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.05246102473982435
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.05246102473982435
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.05246102473982435
LISSENCEPHALY 2; LIS2	0.000545554	0.05246102473982435
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.05246102473982435
MEVALONIC ACIDURIA	0.000545554	0.05246102473982435
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.05246102473982435
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.05246102473982435
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
TOLUENE EMBRYOPATHY	0.000545554	0.05246102473982435
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05246102473982435
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.05246102473982435
PELLAGRA-LIKE SYNDROME	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.05246102473982435
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.05246102473982435
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.05246102473982435
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.05246102473982435
REVESZ SYNDROME	0.000545554	0.05246102473982435
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.05246102473982435
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.05246102473982435
MIETENS SYNDROME	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.05246102473982435
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.05246102473982435
DPAGT1-CDG	0.000545554	0.05246102473982435
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.05246102473982435
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.05246102473982435
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.05246102473982435
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.05246102473982435
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.05246102473982435
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.05246102473982435
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.05246102473982435
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.05246102473982435
RAINE SYNDROME	0.000545554	0.05246102473982435
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.05246102473982435
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.05246102473982435
BRESEK SYNDROME	0.000545554	0.05246102473982435
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.05246102473982435
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.05246102473982435
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.05246102473982435
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.05246102473982435
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.05246102473982435
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.05246102473982435
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.05246102473982435
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.05246102473982435
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.05246102473982435
WAISMAN SYNDROME; WSMN	0.000545554	0.05246102473982435
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.05246102473982435
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000545554	0.05246102473982435
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.05246102473982435
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.05246102473982435
300270 ADRENOMYODYSTROPHY	0.000545554	0.05246102473982435
GLYCEROL KINASE DEFICIENCY; GKD	0.000545554	0.05246102473982435
BIOTINIDASE DEFICIENCY	0.000545554	0.05246102473982435
COLE-CARPENTER SYNDROME	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.05246102473982435
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.05246102473982435
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.05246102473982435
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.05246102473982435
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.05246102473982435
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.05246102473982435
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.05246102473982435
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.05246102473982435
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.05246102473982435
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.05246102473982435
6Q TERMINAL DELETION SYNDROME	0.000545554	0.05246102473982435
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.05246102473982435
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.05246102473982435
BAND HETEROTOPIA; BH	0.000545554	0.05246102473982435
OCULOECTODERMAL SYNDROME; OES	0.000545554	0.05246102473982435
LOWRY-MACLEAN SYNDROME	0.000545554	0.05246102473982435
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.05246102473982435
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.05246102473982435
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.05246102473982435
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.05246102473982435
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.05246102473982435
MONOSOMY 9Q22.3	0.000545554	0.05246102473982435
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.05246102473982435
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.05246102473982435
OGDEN SYNDROME; OGDNS	0.000545554	0.05246102473982435
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.05246102473982435
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.05246102473982435
SCHIZENCEPHALY	0.000545554	0.05246102473982435
HEREDITARY OROTIC ACIDURIA	0.000545554	0.05246102473982435
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.05246102473982435
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.05246102473982435
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.05246102473982435
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.05246102473982435
OCCIPITAL HORN SYNDROME	0.000545554	0.05246102473982435
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.05246102473982435
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.05246102473982435
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.05246102473982435
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.05246102473982435
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.05246102473982435
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.05246102473982435
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.05246102473982435
ALG6-CDG	0.000545554	0.05246102473982435
ALG3-CDG	0.000545554	0.05246102473982435
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.05246102473982435
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.05246102473982435
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.05246102473982435
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.05246102473982435
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.05246102473982435
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.05246102473982435
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.05246102473982435
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.05246102473982435
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.05246102473982435
EAST SYNDROME	0.000545554	0.05246102473982435
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.05246102473982435
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.05246102473982435
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05246102473982435
DISTAL MONOSOMY 9P	0.000545554	0.05246102473982435
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.05246102473982435
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.05246102473982435
DEXTROCARDIA	0.000545554	0.05246102473982435
ZEBRA BODY MYOPATHY	0.000545554	0.05246102473982435
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.05246102473982435
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.05246102473982435
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.05246102473982435
OPITZ G/BBB SYNDROME	0.000545554	0.05246102473982435
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.05246102473982435
BILATERAL POLYMICROGYRIA	0.000545554	0.05246102473982435
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.05246102473982435
20P12.3 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
BOHRING-OPITZ SYNDROME	0.000545554	0.05246102473982435
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.05246102473982435
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.05246102473982435
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.05246102473982435
COFFIN-SIRIS SYNDROME 5	0.000545554	0.05246102473982435
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.05246102473982435
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.05246102473982435
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.05246102473982435
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.05246102473982435
L1 SYNDROME	0.000545554	0.05246102473982435
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.05246102473982435
DISTAL MONOSOMY 6P	0.000545554	0.05246102473982435
DISTAL MONOSOMY 19P13.3	0.000545554	0.05246102473982435
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.05246102473982435
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
RECOMBINANT 8 SYNDROME	0.000545554	0.05246102473982435
MONOSOMY 13Q34	0.000545554	0.05246102473982435
TRISOMY 17P	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.05246102473982435
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.05246102473982435
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.05246102473982435
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.05246102473982435
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.05246102473982435
X SMALL RINGS	0.000545554	0.05246102473982435
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.05246102473982435
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.05246102473982435
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.05246102473982435
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.05246102473982435
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.05246102473982435
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.05246102473982435
MOSAIC TRISOMY 9	0.000545554	0.05246102473982435
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.05246102473982435
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.05246102473982435
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.05246102473982435
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.05246102473982435
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.05246102473982435
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.05246102473982435
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.05246102473982435
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.05246102473982435
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.05246102473982435
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.05246102473982435
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.05246102473982435
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.05246102473982435
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.05246102473982435
8P23.1 DUPLICATION SYNDROME	0.000545554	0.05246102473982435
12Q14 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
CODAS SYNDROME	0.000545554	0.05246102473982435
MEIER-GORLIN SYNDROME 7	0.000545554	0.05246102473982435
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.05246102473982435
2P21 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
CURRARINO SYNDROME	0.000545554	0.05246102473982435
CHAR SYNDROME	0.000545554	0.05246102473982435
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.05246102473982435
ALAZAMI-YUAN SYNDROME	0.000545554	0.05246102473982435
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.05246102473982435
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.05246102473982435
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.05246102473982435
KBG SYNDROME	0.000545554	0.05246102473982435
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.05246102473982435
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.05246102473982435
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.05246102473982435
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.05246102473982435
XP21 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.05246102473982435
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.05246102473982435
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.05246102473982435
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000545554	0.05246102473982435
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.05246102473982435
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.05246102473982435
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.05246102473982435
N SYNDROME	0.000545554	0.05246102473982435
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.05246102473982435
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.05246102473982435
THYROID HEMIAGENESIS	0.000545554	0.05246102473982435
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
MACDERMOT-WINTER SYNDROME	0.000545554	0.05246102473982435
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.05246102473982435
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.05246102473982435
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.05246102473982435
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.05246102473982435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.05246102473982435
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.05246102473982435
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.05246102473982435
WALKER-WARBURG SYNDROME	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.05246102473982435
SENIOR-LOKEN SYNDROME 9	0.000545554	0.05246102473982435
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.05246102473982435
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.05246102473982435
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.05246102473982435
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.05246102473982435
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000545554	0.05246102473982435
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.05246102473982435
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.05246102473982435
JAWAD SYNDROME	0.000545554	0.05246102473982435
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.05246102473982435
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.05246102473982435
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.05246102473982435
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.05246102473982435
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.05246102473982435
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.05246102473982435
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.05246102473982435
ALG11-CDG	0.000545554	0.05246102473982435
WOLF-HIRSCHHORN SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.05246102473982435
OTOFACIOCERVICAL SYNDROME	0.000545554	0.05246102473982435
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.05246102473982435
DISTAL TRISOMY 18Q	0.000545554	0.05246102473982435
LATERAL MENINGOCELE SYNDROME	0.000545554	0.05246102473982435
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.05246102473982435
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.05246102473982435
16P13.11 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.05246102473982435
TRANSALDOLASE DEFICIENCY	0.000545554	0.05246102473982435
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.05246102473982435
MOSAIC TRISOMY 14	0.000545554	0.05246102473982435
TRISOMY 12P	0.000545554	0.05246102473982435
DISTAL TRISOMY 6P	0.000545554	0.05246102473982435
TRISOMY 8Q	0.000545554	0.05246102473982435
WRINKLY SKIN SYNDROME	0.000545554	0.05246102473982435
15Q24 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.05246102473982435
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.05246102473982435
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.05246102473982435
PFEIFFER SYNDROME TYPE 2	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.05246102473982435
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.05246102473982435
TEMTAMY SYNDROME	0.000545554	0.05246102473982435
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.05246102473982435
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.05246102473982435
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.05246102473982435
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.05246102473982435
HARTNUP DISORDER	0.000545554	0.05246102473982435
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.05246102473982435
HOLMES-GANG SYNDROME	0.000545554	0.05246102473982435
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.05246102473982435
W SYNDROME	0.000545554	0.05246102473982435
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.05246102473982435
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.05246102473982435
GERODERMA OSTEODYSPLASTICA	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.05246102473982435
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.05246102473982435
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.05246102473982435
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.05246102473982435
LISSENCEPHALY 4	0.000545554	0.05246102473982435
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.05246102473982435
TRISOMY X	0.000545554	0.05246102473982435
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05246102473982435
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.05246102473982435
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.05246102473982435
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.05246102473982435
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.05246102473982435
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.05246102473982435
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.05246102473982435
19P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.05246102473982435
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05246102473982435
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.05246102473982435
TRISOMY 18	0.000545554	0.05246102473982435
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.05246102473982435
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.05246102473982435
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.05246102473982435
HOLOPROSENCEPHALY 11	0.000545554	0.05246102473982435
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.05246102473982435
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.05246102473982435
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.05246102473982435
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.05246102473982435
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.05246102473982435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.05246102473982435
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.05246102473982435
DISTAL TRISOMY 17Q	0.000545554	0.05246102473982435
COG2-CDG	0.000545554	0.05246102473982435
MICROVILLUS INCLUSION DISEASE	0.000545554	0.05246102473982435
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.05246102473982435
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.05246102473982435
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.05246102473982435
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.05246102473982435
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.05246102473982435
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.05246102473982435
TETRASOMY 5P	0.000545554	0.05246102473982435
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.05246102473982435
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.05246102473982435
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.05246102473982435
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.05246102473982435
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.05246102473982435
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.05246102473982435
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.05246102473982435
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.05246102473982435
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.05246102473982435
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.05246102473982435
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
CHAR SYNDROME	0.000545554	0.05246102473982435
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.05246102473982435
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.05246102473982435
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.05246102473982435
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.05246102473982435
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.05246102473982435
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.05246102473982435
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.05246102473982435
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.05246102473982435
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.05246102473982435
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.05246102473982435
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.05246102473982435
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.05246102473982435
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.05246102473982435
INCONTINENTIA PIGMENTI	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.05246102473982435
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05246102473982435
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.05246102473982435
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.05246102473982435
DYSTONIA-APHONIA SYNDROME	0.000545554	0.05246102473982435
1Q44 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.05246102473982435
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.05246102473982435
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.05246102473982435
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.05246102473982435
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.05246102473982435
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.05246102473982435
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.05246102473982435
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.05246102473982435
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.05246102473982435
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.05246102473982435
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.05246102473982435
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.05246102473982435
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.05246102473982435
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.05246102473982435
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.05246102473982435
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.05246102473982435
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.05246102473982435
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.05246102473982435
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.05246102473982435
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05246102473982435
STEEL SYNDROME; STLS	0.000545554	0.05246102473982435
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.05246102473982435
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.05246102473982435
DISTAL MONOSOMY 1Q	0.000545554	0.05246102473982435
ALAZAMI SYNDROME; ALAZS	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.05246102473982435
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.05246102473982435
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.05246102473982435
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.05246102473982435
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.05246102473982435
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.05246102473982435
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.05246102473982435
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.05246102473982435
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.05246102473982435
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.05246102473982435
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.05246102473982435
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.05246102473982435
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.05246102473982435
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.05246102473982435
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.05246102473982435
RAHMAN SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.05246102473982435
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.05246102473982435
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.05246102473982435
USHER SYNDROME TYPE 1	0.000545554	0.05246102473982435
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.05246102473982435
YUNIS-VARON SYNDROME	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.05246102473982435
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.05246102473982435
DUANE RETRACTION SYNDROME	0.000545554	0.05246102473982435
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05246102473982435
MARDEN-WALKER SYNDROME	0.000545554	0.05246102473982435
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.05246102473982435
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.05246102473982435
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05246102473982435
EPIDERMAL NEVUS SYNDROME	0.000545554	0.05246102473982435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.05246102473982435
ISOLATED PLAGIOCEPHALY	0.000545554	0.05246102473982435
MECKEL SYNDROME 13; MKS13	0.000545554	0.05246102473982435
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.05246102473982435
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.05246102473982435
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.05246102473982435
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.05246102473982435
KBG SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.05246102473982435
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.05246102473982435
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.05246102473982435
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05246102473982435
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.05246102473982435
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.05246102473982435
DONNAI-BARROW SYNDROME	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.05246102473982435
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.05246102473982435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.05246102473982435
SENIOR-LOKEN SYNDROME	0.000545554	0.05246102473982435
PHACE ASSOCIATION	0.000545554	0.05246102473982435
SEVERE CANAVAN DISEASE	0.000545554	0.05246102473982435
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.05246102473982435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.05246102473982435
NARP SYNDROME	0.000545554	0.05246102473982435
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.05246102473982435
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.05246102473982435
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.05246102473982435
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.05246102473982435
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.05246102473982435
LEBER CONGENITAL AMAUROSIS	0.000545554	0.05246102473982435
MEDULLOBLASTOMA	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.05246102473982435
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.05246102473982435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.05246102473982435
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.05246102473982435
ATELOSTEOGENESIS TYPE III	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.05246102473982435
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.05246102473982435
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.05246102473982435
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.05246102473982435
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.05246102473982435
LISSENCEPHALY 1; LIS1	0.000545554	0.05246102473982435
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.05246102473982435
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.05246102473982435
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.05246102473982435
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.05246102473982435
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.05246102473982435
HARTNUP DISEASE	0.000545554	0.05246102473982435
FRONTOOCULAR SYNDROME	0.000545554	0.05246102473982435
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.05246102473982435
CURRY-JONES SYNDROME	0.000545554	0.05246102473982435
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.05246102473982435
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.05246102473982435
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.05246102473982435
OPTIC PATHWAY GLIOMA	0.000545554	0.05246102473982435
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.05246102473982435
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.05246102473982435
NOONAN SYNDROME 2; NS2	0.000545554	0.05246102473982435
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.05246102473982435
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05246102473982435
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.05246102473982435
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.05246102473982435
OXOGLUTARIC ACIDURIA	0.000545554	0.05246102473982435
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.05246102473982435
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.05246102473982435
SARCOSINEMIA	0.000545554	0.05246102473982435
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.05246102473982435
SAY-BARBER-MILLER SYNDROME	0.000545554	0.05246102473982435
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.05246102473982435
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.05246102473982435
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.05246102473982435
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.05246102473982435
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.05246102473982435
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.05246102473982435
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.05246102473982435
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.05246102473982435
PALLISTER-HALL SYNDROME	0.000545554	0.05246102473982435
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.05246102473982435
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.05246102473982435
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.05246102473982435
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.05246102473982435
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.05246102473982435
ICF SYNDROME	0.000545554	0.05246102473982435
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.05246102473982435
FILIPPI SYNDROME	0.000545554	0.05246102473982435
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.05246102473982435
CULLER-JONES SYNDROME; CJS	0.000545554	0.05246102473982435
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.05246102473982435
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.05246102473982435
NOONAN SYNDROME 5; NS5	0.000545554	0.05246102473982435
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.05246102473982435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.05246102473982435
2Q31.1 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000545554	0.05246102473982435
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.05246102473982435
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.05246102473982435
HYPERTRICHOSIS CUBITI	0.000545554	0.05246102473982435
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.05246102473982435
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.05246102473982435
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.05246102473982435
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.05246102473982435
ISOVALERIC ACIDEMIA	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.05246102473982435
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.05246102473982435
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.05246102473982435
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.05246102473982435
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.05246102473982435
GLASS SYNDROME	0.000545554	0.05246102473982435
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.05246102473982435
KRABBE DISEASE	0.000545554	0.05246102473982435
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000545554	0.05246102473982435
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.05246102473982435
SECKEL SYNDROME 8; SCKL8	0.000545554	0.05246102473982435
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.05246102473982435
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.05246102473982435
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.05246102473982435
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.05246102473982435
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.05246102473982435
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.05246102473982435
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.05246102473982435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.05246102473982435
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.05246102473982435
8P23.1 MICRODELETION SYNDROME	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.05246102473982435
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.05246102473982435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.05246102473982435
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.05246102473982435
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.05246102473982435
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.05246102473982435
HYDRANENCEPHALY	0.000545554	0.05246102473982435
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.05246102473982435
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 2	0.000545554	0.05246102473982435
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.05246102473982435
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.05246102473982435
FRIAS SYNDROME	0.000545554	0.05246102473982435
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000545554	0.05246102473982435
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.05246102473982435
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.05246102473982435
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.05246102473982435
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.05246102473982435
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.05246102473982435
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.05246102473982435
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.05246102473982435
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.05246102473982435
8P11.2 DELETION SYNDROME	0.000545554	0.05246102473982435
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05246102473982435
MATERNAL PHENYLKETONURIA	0.000545554	0.05246102473982435
MAPLE SYRUP URINE DISEASE	0.000545554	0.05246102473982435
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.05246102473982435
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.05246102473982435
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.05246102473982435
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.05246102473982435
JOUBERT SYNDROME WITH RENAL DEFECT	0.000545554	0.05246102473982435
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.05246102473982435
NOONAN SYNDROME 3; NS3	0.000545554	0.05246102473982435
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.05246102473982435
